<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>List of countries by antidepressant consumption</title><meta name="description" content="A list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization&#x27;s defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability. This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/List_of_countries_by_antidepressant_consumption"/><meta property="og:title" content="List of countries by antidepressant consumption"/><meta property="og:description" content="A list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization&#x27;s defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability. This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest..."/><meta property="og:url" content="https://grokipedia.com/page/List_of_countries_by_antidepressant_consumption"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="List of countries by antidepressant consumption"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:42.322Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="List of countries by antidepressant consumption"/><meta name="twitter:description" content="A list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization&#x27;s defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability. This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="202e357f6728f9e40506b884e02ea704-e8f3955ec175aa4b-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=202e357f6728f9e40506b884e02ea704,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.9964591386953934,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#list-of-countries-by-antidepressant-consumption" class="transition-opacity hover:opacity-100 opacity-50">List of countries by antidepressant consumption</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#data-sources-and-methodology" class="transition-opacity hover:opacity-100 opacity-50">Data Sources and Methodology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#oecd-standardized-metrics" class="transition-opacity hover:opacity-100 opacity-50">OECD Standardized Metrics</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#alternative-datasets-and-limitations" class="transition-opacity hover:opacity-100 opacity-50">Alternative Datasets and Limitations</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#current-global-rankings" class="transition-opacity hover:opacity-100 opacity-50">Current Global Rankings</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#highest-consumption-countries" class="transition-opacity hover:opacity-100 opacity-50">Highest Consumption Countries</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#lowest-consumption-countries" class="transition-opacity hover:opacity-100 opacity-50">Lowest Consumption Countries</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#regional-patterns" class="transition-opacity hover:opacity-100 opacity-50">Regional Patterns</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#historical-and-temporal-trends" class="transition-opacity hover:opacity-100 opacity-50">Historical and Temporal Trends</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#increases-since-2000" class="transition-opacity hover:opacity-100 opacity-50">Increases Since 2000</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#post-2010-accelerations" class="transition-opacity hover:opacity-100 opacity-50">Post-2010 Accelerations</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pandemic-era-shifts" class="transition-opacity hover:opacity-100 opacity-50">Pandemic-Era Shifts</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#determinants-of-variation" class="transition-opacity hover:opacity-100 opacity-50">Determinants of Variation</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#healthcare-access-and-prescribing-practices" class="transition-opacity hover:opacity-100 opacity-50">Healthcare Access and Prescribing Practices</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#economic-and-cultural-influences" class="transition-opacity hover:opacity-100 opacity-50">Economic and Cultural Influences</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#diagnostic-and-regulatory-factors" class="transition-opacity hover:opacity-100 opacity-50">Diagnostic and Regulatory Factors</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#associations-with-outcomes" class="transition-opacity hover:opacity-100 opacity-50">Associations with Outcomes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#links-to-suicide-and-mortality-rates" class="transition-opacity hover:opacity-100 opacity-50">Links to Suicide and Mortality Rates</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#correlations-with-self-reported-mental-health" class="transition-opacity hover:opacity-100 opacity-50">Correlations with Self-Reported Mental Health</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#evidence-on-treatment-effectiveness" class="transition-opacity hover:opacity-100 opacity-50">Evidence on Treatment Effectiveness</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#debates-and-critiques" class="transition-opacity hover:opacity-100 opacity-50">Debates and Critiques</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#overprescription-concerns" class="transition-opacity hover:opacity-100 opacity-50">Overprescription Concerns</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharma-influence-and-profit-motives" class="transition-opacity hover:opacity-100 opacity-50">Pharma Influence and Profit Motives</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cross-cultural-interpretations" class="transition-opacity hover:opacity-100 opacity-50">Cross-Cultural Interpretations</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="list-of-countries-by-antidepressant-consumption" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">List of countries by antidepressant consumption<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">
A list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization&#x27;s defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_60qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest rate at 157 DDD per 1,000 inhabitants per day in recent assessments, followed closely by Portugal, Canada, Australia, and Sweden.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Overall OECD consumption of these drugs escalated by approximately 50% between 2011 and 2021, a trend amplified in countries such as Chile and South Korea where it more than doubled, amid rising mental disorder prevalence estimates affecting one in six Europeans.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Such disparities fuel inquiries into causal factors including healthcare access, diagnostic expansion, and potential overprescription, particularly in affluent nations where usage correlates imperfectly with self-reported happiness or suicide rates, suggesting influences beyond raw pathology like cultural attitudes toward pharmacotherapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></span>
<h2 id="data-sources-and-methodology" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Data Sources and Methodology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="oecd-standardized-metrics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">OECD Standardized Metrics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
The OECD employs the defined daily dose (DDD) per 1,000 inhabitants per day as the primary metric for standardizing antidepressant consumption, a system defined by the World Health Organization (WHO) as the assumed average maintenance dose per day for a drug&#x27;s main indication in adults.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_62abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> This measure, applied to antidepressants under the Anatomical Therapeutic Chemical (ATC) classification code N06Aâ€”which encompasses selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other agentsâ€”facilitates empirical cross-country comparability by accounting for differences in dosing assumptions rather than raw sales or prescriptions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">By converting wholesale, distribution, or reimbursement data into DDD equivalents, the methodology minimizes distortions from varying national prescribing patterns, generic availability, or over-the-counter access, yielding a consistent indicator of population-level utilization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> OECD data, harmonized for 38 member countries where available, cover periods up to 2020-2022 depending on national reporting, with the aggregate average rising from 52.4 DDD per 1,000 inhabitants per day in 2010 to 69.5 in 2020.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Notable variations within this framework include Iceland&#x27;s consumption surpassing 100 DDD, reaching 153 in 2020 assessments, and Portugal&#x27;s at 131 DDD, underscoring the metric&#x27;s capacity to reveal disparities while maintaining standardization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> These figures derive from aggregated pharmaceutical distribution records, ensuring reliance on verifiable wholesale quantities adjusted for population demographics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<h3 id="alternative-datasets-and-limitations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Alternative Datasets and Limitations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In addition to OECD data, alternative datasets on antidepressant consumption include those derived from the World Health Organization&#x27;s (WHO) Anatomical Therapeutic Chemical (ATC) classification system, which standardizes defined daily doses (DDD) per 1,000 inhabitants per day across broader global samples, though with varying national reporting quality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Our World in Data aggregates such WHO-sourced figures, enabling cross-country comparisons but relying on voluntary submissions that often exclude low-reporting regions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Private sector analyses, such as IQVIA&#x27;s Multinational Integrated Data Analysis System (MIDAS), track pharmaceutical sales volumes from 2014 onward across up to 65 countries, providing granular wholesaler and retail data adjusted for population but limited to commercial markets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Methodological variances arise in coverage and granularity; for instance, World Population Review compiles 2016â€“2020 averages from diverse sources including national registries, extending to non-OECD nations like Serbia where OECD data is absent, yet these aggregates may incorporate less standardized imputation for gaps, leading to potential divergences from OECD&#x27;s pharmacy-dispensed DDD metrics focused on high-income members.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> National registries, such as those in Nordic countries via administrative health databases, offer high-fidelity outpatient prescription records but emphasize domestic rather than comparative metrics, differing from OECD&#x27;s harmonized international benchmarking.00292-3.pdf) Emphasis across these sources remains on population-adjusted DDD over raw volumes to account for demographic scale, though discrepancies persist due to differing inclusion of generics or formulation variants.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Key limitations include systemic underreporting in low- and middle-income countries (LMICs), where data scarcity stems from fragmented pharmacovigilance and limited electronic health systems, resulting in prevalence estimates 2â€“4 times lower than in high-income settings despite comparable mental health burdens.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_45abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> Most datasets prioritize outpatient dispensing or sales, often omitting inpatient hospital administrations which can constitute 10â€“20% of total use in acute settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_85abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Over-the-counter or informal black-market consumption is excluded entirely, as antidepressants are strictly prescription-controlled in monitored jurisdictions, potentially understating actual intake in regions with weak regulatory enforcement.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> These gaps underscore the need for triangulating multiple verifiable sources to mitigate biases toward well-documented high-income data.</span>
<h2 id="current-global-rankings" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Current Global Rankings<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="highest-consumption-countries" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Highest Consumption Countries<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Iceland consistently ranks as the country with the highest antidepressant consumption, recording 157.3 defined daily doses (DDD) per 1,000 inhabitants per day in 2022.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup> Portugal follows closely, with consumption reaching 154.4 DDD per 1,000 inhabitants per day in 2023.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> These figures reflect standardized OECD metrics for pharmaceutical use, focusing on ATC code N06A drugs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Analyses of OECD data from 2016 to 2020 identify Iceland, Portugal, Canada, Australia, and Sweden as the top consumers overall.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> A comparative study of 30 OECD countries up to 2020 reported Iceland at 153 DDD and Portugal at 131 DDD, underscoring sustained high levels in these nations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_87abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>






























<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Country</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">DDD per 1,000 inhabitants/day</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Year</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Iceland</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">157.3</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2022</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Portugal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">154.4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2023</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Iceland</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">153</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2020</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Portugal</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">131</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2020</span></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<h3 id="lowest-consumption-countries" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Lowest Consumption Countries<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Countries exhibiting the lowest levels of antidepressant consumption, as measured by defined daily doses (DDD) per 1,000 inhabitants per day, stand in stark contrast to higher-use nations, with rates often below 50 DDD compared to the OECD average of approximately 70 DDD in 2020.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Latvia recorded 20 DDD in 2020, the lowest among European OECD countries analyzed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> South Korea maintained relatively low usage at 31.1 DDD in recent data, despite a doubling of consumption from prior baselines between 2011 and 2021.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Turkey reported 49 DDD in 2020, below the OECD mean, reflecting patterns in larger emerging economies within the organization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i9abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">These figures, derived primarily from OECD pharmaceutical sales and prescription data, indicate stability or modest growth in low-consumption countries over the 2010-2020 period, contrasting with steeper rises elsewhere.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> For instance, while the OECD-wide mean climbed from 52.4 DDD in 2010 to 69.5 DDD in 2020, low-use nations like those listed showed linear or concave trends with annual increases under 2 DDD on average.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Such disparities challenge uniform narratives of mental health treatment needs, as DDD metrics capture prescribed volumes rather than diagnosed prevalence or self-reported distress, potentially influenced by cultural stigma, alternative coping mechanisms, or diagnostic practices.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Data limitations include incomplete coverage for non-OECD nations like Mexico, where consumption is presumed low based on regional patterns in Latin America but lacks standardized DDD reporting.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The following table summarizes select lowest-consumption OECD countries for context against the average:</span>





























<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Country</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">DDD per 1,000 Inhabitants per Day</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Year</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Relative to OECD Average</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Latvia</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">20</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2020</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~29%</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">South Korea</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">31.1</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~2022</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~44%</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Turkey</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">49</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2020</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~70%</span></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">OECD average: ~70 DDD (2020).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">These patterns persist despite global pressures like the COVID-19 pandemic, which prompted increases across most OECD members but proportionally less in low-baseline countries, underscoring variability in prescribing responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> Empirical evidence does not conclusively link low DDD to adverse outcomes, as cross-national suicide rates and well-being metrics vary independently; for example, South Korea&#x27;s high suicide rate coexists with low antidepressant use, potentially tied to other factors like economic stress rather than pharmacological underutilization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup> Source credibility in such data relies on standardized OECD methodologies, though extensions to non-members introduce estimation errors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ccabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></span>
<h3 id="regional-patterns" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Regional Patterns<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In Europe, antidepressant consumption exhibits elevated and variable patterns, with Northern countries such as Iceland and Sweden among the global leaders at rates exceeding 100 defined daily doses (DDD) per 1,000 inhabitants per day in recent OECD assessments, while Southern Europe includes outliers like Portugal with comparably high utilization around 120 DDD per 1,000.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Across 18 European nations, the regional average rose from 30.5 DDD per 1,000 in 2000 to 75.3 DDD per 1,000 in 2020, though exceptions like Denmark show rare instances of stagnation or decline amid broader increases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_adabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">North America displays consistently high consumption, driven by rates in Canada and the United States surpassing 80 DDD per 1,000 inhabitants per day in OECD-tracked data through 2021, positioning the region alongside Europe and Oceania as a cluster of peak utilization.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In contrast, Asia and Africa feature generally low consumption levels, with Asian OECD members like South Korea recording under 35 DDD per 1,000 despite recent doublings, and African data remaining sparse due to limited pharmaceutical tracking, implying rates far below global highs based on available WHO and IQVIA aggregates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Latin America shows emerging but subdued patterns, exemplified by Chile&#x27;s tripling to moderate levels over the 2010s, yet still trailing high-income regions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aeabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<h2 id="historical-and-temporal-trends" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Historical and Temporal Trends<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="increases-since-2000" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Increases Since 2000<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Antidepressant consumption, measured in defined daily doses (DDD) per 1,000 inhabitants per day, has exhibited consistent upward trends across OECD countries since 2000. Analyses of OECD data indicate that consumption increased in every examined member country between 2000 and 2011, with an overall rise of approximately 65% across 34 nations during this period.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> This baseline expansion established a foundation for subsequent growth, reflecting broader adoption of these medications in primary care and outpatient settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In a subset of 18 European OECD countries, average consumption rose from 30.5 DDD per 1,000 inhabitants per day in 2000 to 75.3 DDD by 2020, more than doubling over two decades.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> Country-specific data from the early period highlight varied but uniformly positive increments; for instance, Iceland&#x27;s consumption climbed from 71 DDD in 2000 to 130 DDD in 2011, while Australia&#x27;s increased from 45 DDD to 89 DDD.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> The following table summarizes decade-over-decade changes for select OECD countries based on available standardized metrics:</span>



































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Country</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">2000 DDD</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">2011 DDD</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">% Increase (2000-2011)</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Iceland</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">71</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">130</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">83%</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Australia</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">45</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">89</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Canada</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~40</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~67</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">68%</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">United Kingdom</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~30</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">~54</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">80%</span></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">These figures, derived from OECD pharmaceutical sales data adjusted for population, underscore the pervasive nature of the rise without exception in the sampled jurisdictions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> By the mid-2010s, the trajectory had begun to accelerate in many regions, setting the stage for further elevations into the 2020s, though baseline patterns originated in the post-2000 era.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<h3 id="post-2010-accelerations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Post-2010 Accelerations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">From 2010 to 2020, the average antidepressant consumption across 30 OECD countries rose from 52.42 defined daily doses (DDD) per 1,000 inhabitants per day to 69.5 DDD, marking a period of accelerated growth beyond prior trends.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup> This increase, equivalent to nearly a 33% rise over the decade, was evident in the majority of analyzed nations, with annual increments averaging 1.68 DDD per 1,000 inhabitants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> Trend analyses identified linear upward trajectories in most cases, alongside concave patterns indicating initial slower growth followed by steeper rises, and convex patterns with early surges tapering later.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ciabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Notable accelerations occurred in specific countries, including Australia, where consumption reached 106.7 DDD per 1,000 inhabitants by 2016, reflecting a sharp escalation from earlier baselines.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> In Portugal, antidepressant use surged, with defined daily doses increasing by over 15 DDD per 1,000 inhabitants per day by the early 2020s, building on post-2010 momentum driven by expanded access and prescribing.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> Sweden similarly saw heightened usage, with prevalence rates climbing from 78 to 107 users per 1,000 inhabitants between 2006 and 2021, aligning with DDD trends emphasizing sustained post-2010 expansion in Nordic contexts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ciqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> These patterns were underpinned by the growing dominance of selective serotonin reuptake inhibitors (SSRIs), which accounted for the bulk of incremental prescriptions across OECD datasets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_giqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Overall, the decade post-2010 demonstrated empirically verifiable sharpening in consumption trajectories, with OECD-wide data confirming broad-based growth rather than isolated anomalies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> This period&#x27;s dynamics highlighted a convergence toward higher utilization norms, particularly in Western Europe and Anglosphere nations, as captured in standardized DDD metrics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<h3 id="pandemic-era-shifts" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pandemic-Era Shifts<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In Canada, antidepressant dispensing volumes rose substantially during the pandemic period, with over 2.5 billion units dispensed nationwide in 2022 alone, marking a 19.5% increase from 2019 levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> Between 2019 and 2023, prevalence rates increased across all provinces except Ontario, driven by higher utilization in younger age groups under 65; the Atlantic provinces exhibited the highest per capita rates in 2023.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">European countries displayed heterogeneous patterns in outpatient antidepressant dispensing from 2020 to 2023, with accelerations in several nations amid the pandemic. Portugal recorded a sharp rise, with consumption climbing by 15.6 defined daily doses (DDD) per 1,000 inhabitants per day in 2023 relative to 2022.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> Spain saw a comparable uptick of 5.7 DDD per 1,000 in 2022 over the previous year, reflecting sustained growth into the post-acute phase.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> Sweden maintained elevated prevalence, with user rates per 1,000 inhabitants advancing from 107 in earlier pandemic years through 2021, outpacing Nordic peers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ckqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Outliers emerged where pre-pandemic downward trajectories stabilized or moderated. In Denmark, incident antidepressant use, which had declined prior to 2020, leveled off or slowed during and after the pandemic, contrasting broader regional increases of 13.5% to 31.3% in filled prescriptions by late 2020.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> These shifts coincided with policy adaptations like expanded telehealth but did not uniformly correlate with infection rates or lockdown stringency across datasets up to 2023.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_alabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup></span>
<h2 id="determinants-of-variation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Determinants of Variation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="healthcare-access-and-prescribing-practices" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Healthcare Access and Prescribing Practices<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Countries with universal healthcare coverage, particularly in the Nordic region, demonstrate elevated antidepressant consumption due to reduced financial and logistical barriers to primary care consultations and prescriptions. In Norway, for example, the national health system provides comprehensive coverage for general practitioner visits, enabling widespread access to mental health evaluations and pharmacotherapy without out-of-pocket costs deterring uptake.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup> This contrasts with lower-consumption regions featuring fragmented or under-resourced systems, where limited reimbursement and provider shortages restrict prescribing volume; OECD data across member states show antidepressant use rising 50% from 2011 to 2021 in high-access environments, outpacing gains in less integrated systems.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Prescribing practices vary by drug class, with a shift toward selective serotonin reuptake inhibitors (SSRIs) in outpatient-oriented systems correlating to higher overall consumption, as these agents are favored for their tolerability and ease of initiation in primary care. Multinational analyses reveal SSRIs dominating new prescriptions in older adults across Europe, comprising the majority of antidepressant initiations in countries emphasizing ambulatory care over inpatient treatment.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> In contrast, older tricyclic antidepressants persist in select settings with inpatient focus or regulatory preferences, but their lower prevalence in accessible outpatient models contributes to disparities; for instance, European utilization studies document SSRI shares exceeding 70% of total antidepressant defined daily doses in nations like the Netherlands and Sweden.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Empirical evidence from European cohorts links physical disability and comorbid health conditions to increased antidepressant prescriptions, independent of mental health diagnoses alone, as providers address overlapping symptoms through pharmacotherapy. A repetitive cross-sectional analysis across 19 European countries found individuals with physical disabilities were more likely to receive antidepressants in 13 nations, attributing this to integrated care pathways where disability assessments prompt broader prescribing.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup> Similarly, studies on transitions to disability pensions show heightened prescription rates preceding awards for conditions like back pain, reflecting practitioner incentives tied to holistic symptom management under public reimbursement frameworks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> These patterns underscore how systemic access amplifies prescribing for disability-related indications, driving consumption variances without implying diagnostic overreach.</span>
<h3 id="economic-and-cultural-influences" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Economic and Cultural Influences<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">A positive correlation exists between gross domestic product (GDP) per capita and antidepressant consumption across European countries. Analysis of selective serotonin reuptake inhibitor (SSRI) use in 13 European nations in 2019 revealed a Spearman&#x27;s rank correlation coefficient of Ï = 0.714 (p = 0.0081), indicating that wealthier economies tend to exhibit higher per capita consumption rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> This pattern extends to broader OECD data, where elevated GDP per capita stimulates overall antidepressant demand, potentially reflecting greater affordability and integration of pharmacotherapy into routine care.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> Such associations suggest economic capacity enables expanded prescribing, though they do not imply proportional increases in underlying disorder prevalence.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Cultural attitudes toward mental illness significantly influence consumption disparities. In Asia, pervasive stigma frames psychiatric conditions as familial dishonor, deterring help-seeking and pharmacotherapy; for instance, affected individuals face diminished marriage prospects and economic opportunities, fostering underreporting and avoidance of antidepressants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> This contrasts with Europe, where variations in public perceptionsâ€”such as acceptance of biomedical explanations for depressionâ€”partly account for prescribing differences across 27 countries, despite comparable affective disorder prevalence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> Empirical evidence indicates these contextual factors drive utilization gaps beyond clinical necessities, as antidepressant uptake correlates more strongly with societal norms than with uniform diagnostic rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_epabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup></span>
<h3 id="diagnostic-and-regulatory-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Diagnostic and Regulatory Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Variations in antidepressant consumption across countries are influenced by differences in diagnostic practices, where expansions in criteria or heightened awareness have not always aligned with empirical increases in severe cases. A 2013 OECD analysis of member states revealed that antidepressant use had risen sharplyâ€”doubling or tripling in many nations over the prior decadeâ€”yet this growth was not matched by proportional increases in diagnosed depression prevalence, prompting concerns over diagnostic inflation and off-label prescribing for milder symptoms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup> Empirical studies support mismatches, with meta-analyses indicating that placebo response rates in depression trials (often exceeding 30%) suggest many cases labeled as major depressive disorder may remit without intervention, implying overdiagnosis in broader diagnostic nets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Evidence of overdiagnosis is particularly evident in pediatric populations, where psychotropic medication prevalence highlights transatlantic disparities. A 2008 comparative study across healthcare systems found the annual rate of any psychotropic use among youth aged 0-18 was 6.7% in the United States, compared to 2.9% in the Netherlands and 2.0% in Germany, despite similar underlying mental health burdens; this gap persists amid critiques that U.S. diagnostic thresholds for conditions like ADHD and depression are lower, leading to higher antidepressant initiation without commensurate severity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup> Such patterns underscore how diagnostic expansionsâ€”often driven by guideline updates favoring pharmacological interventionâ€”can inflate consumption independent of true epidemiological shifts.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Regulatory frameworks further modulate access and prescribing thresholds, with Western nations generally permitting broader indications than in regions with stricter oversight. In the United States, antidepressants like fluoxetine received FDA approval for pediatric depression in 2002 following controlled trials, facilitating prescriptions despite subsequent black-box warnings on suicidality risks, whereas European Medicines Agency (EMA) restrictions in several countries limit approvals for under-18s to severe cases only, correlating with lower youth utilization rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup> Countries like the United Kingdom, adhering to conservative National Institute for Health and Care Excellence (NICE) guidelines that prioritize psychotherapy for mild-to-moderate depression, exhibit among the lowest per-capita consumption in older adults, illustrating how regulatory conservatism curbs volume compared to more permissive U.S. practices.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> These differences persist despite harmonized pharmacovigilance, as national agencies tailor approvals to local evidence thresholds and cost-benefit analyses.</span>
<h2 id="associations-with-outcomes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Associations with Outcomes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="links-to-suicide-and-mortality-rates" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Links to Suicide and Mortality Rates<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
Empirical studies examining national-level data on antidepressant consumption and suicide rates have yielded mixed results, with no robust evidence of a strong negative correlation. A analysis of OECD countries identified a statistically significant but weak association between antidepressant prescribing rates and suicide rates, suggesting limited explanatory power for consumption in reducing suicides.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6sqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup> Similarly, an ecological study across European nations found no association between the introduction and increased prescribing of antidepressants and subsequent declines in suicide rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_asqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the United States, antidepressant prescription prevalence rose alongside suicide rates from 1990 to 2020, indicating persistence of suicides despite expanded access to these medications.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup> High-consumption countries like Iceland, with 141.4 defined daily doses (DDD) per 1,000 inhabitants in 2017, and Portugal, at 103.6 DDD, do not exhibit proportionally low suicide rates; Portugal, in particular, shows a positive correlation between antidepressant utilization and standardized suicide death rates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup> Low-consumption nations display variable suicide outcomes, with some like South Korea experiencing elevated rates despite minimal use, underscoring multifactorial influences beyond pharmacotherapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ctabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regarding overall mortality, population-level data linking antidepressant consumption to reduced all-cause deaths are scarce, while critiques highlight potential long-term risks such as treatment dependency and withdrawal effects that could elevate vulnerability to adverse health outcomes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> These patterns challenge assumptions of straightforward efficacy at the societal scale, as confounders including economic factors, healthcare access, and diagnostic practices likely mediate observed variations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup></span>
<h3 id="correlations-with-self-reported-mental-health" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Correlations with Self-Reported Mental Health<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
In Europe, mental health conditions affect approximately one in six individuals, with around 84 million people impacted as of 2019, encompassing disorders such as depression and anxiety.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup> However, antidepressant consumption rates exhibit substantial variation across European Union member states, ranging from highs in Nordic countries like Iceland and Sweden to lower levels elsewhere, without a direct proportional alignment to self-reported prevalence of depressive symptoms.00061-8/fulltext) A 2022 cross-sectional analysis across 19 European countries found that while antidepressant usage among those reporting depressive symptoms has risen, with prevalence increasing from 36.5% to 50.0% between waves, inter-country and subgroup differences persist independently of symptom severity, indicating influences such as socioeconomic factors and healthcare access beyond raw incidence.00061-8/fulltext)</span>
<span class="mb-4 block break-words text-[1em] leading-7">Nordic nations exemplify discrepancies between high antidepressant consumption and favorable self-reported well-being metrics. Iceland leads globally in per capita antidepressant use, yet consistently ranks among the top in the World Happiness Report&#x27;s life evaluation scores, alongside Denmark, Finland, and Sweden, which also feature elevated consumption ratesâ€”Finland, for instance, reported 81 daily defined doses per 1,000 inhabitants in recent OECD dataâ€”while maintaining high self-assessed happiness levels as of 2024 rankings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup>  These patterns suggest that increased labeling or willingness to medically address milder symptoms, rather than elevated underlying distress, may drive usage in environments with robust mental health awareness and access.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In contrast, the United States exhibits high antidepressant consumptionâ€”around 17% of adults used such medications in recent surveysâ€”paired with middling self-reported mental health outcomes, including a decline to 23rd in global happiness rankings by 2024, where younger cohorts report notably lower life satisfaction than older groups.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8vqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup> European studies further reveal that self-reported poor mental health correlates with higher prescription redemption probabilities, yet aggregate country-level data show only partial positive associations, with cultural and diagnostic practices modulating the link.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cvqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup> 00061-8/fulltext) Such variances imply that self-reported metrics capture subjective perceptions influenced by societal norms on symptom acknowledgment, rather than purely objective disease burden.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gvqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup></span>
<h3 id="evidence-on-treatment-effectiveness" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Evidence on Treatment Effectiveness<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Meta-analyses of randomized controlled trials demonstrate that antidepressants yield modest symptom reduction in major depressive disorder compared to placebo, with standardized mean differences typically ranging from 0.30 to 0.50. A 2018 network meta-analysis encompassing 522 double-blind RCTs involving over 116,000 participants concluded that all 21 antidepressants examined outperformed placebo in acute treatment, though head-to-head differences among agents were small and acceptability varied.32802-7/fulltext) Effect sizes, however, depend on depression severity: benefits are negligible or absent in mild cases, where placebo responses are high, but increase modestly in moderate to severe depression, with drug-placebo differences remaining limited even among severely ill patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_50qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_70qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Long-term maintenance trials reveal elevated relapse risks upon discontinuation, underscoring potential causal dependence on continued pharmacotherapy. Across 11 studies, one-year relapse rates were 23% for active antidepressant versus 51% for placebo.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup> A 2021 primary care RCT of 478 patients in remission reported cumulative relapse incidences of 39% in the maintenance group and 56% in the discontinuation group by 52 weeks, with a hazard ratio of 1.61 favoring continuation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> These findings from placebo-controlled designs suggest short-term gains may not translate to sustained remission without ongoing treatment, though absolute relapse prevention diminishes over time.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Cross-nationally, elevated antidepressant consumption shows no consistent association with superior population-level mental health outcomes, challenging assumptions of broad causal efficacy. An analysis of country-level data found that rises in antidepressant prescribing from 2000 to 2019 correlated neither with reduced prevalence of sadness symptoms nor with lower depressive disorder rates, despite marked increases in use in high-consuming nations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup> Similarly, a 2022 European study across 19 countries observed that higher usage among those with depressive symptoms aligned with fewer psychiatric beds per capita but yielded no improvements in self-reported mental health metrics or suicide rates.00061-8/fulltext) Such patterns imply that pharmacological expansion may address symptoms selectively rather than driving systemic recovery, particularly where diagnostic expansion precedes consumption surges.</span>
<h2 id="debates-and-critiques" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Debates and Critiques<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="overprescription-concerns" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Overprescription Concerns<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Rising antidepressant consumption across OECD countries has raised alarms about overprescription, as usage surges have not been accompanied by proportional increases in diagnosed depression rates. A 2013 OECD analysis highlighted that antidepressant consumption doubled or more in several nations between 2000 and 2011, prompting fears of overuse driven by factors beyond clinical necessity, such as expanded indications for milder symptoms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup> European psychiatrists have warned that this trend reflects a &quot;medicalisation of misery,&quot; with prescribing pressures leading to antidepressants being issued for transient unhappiness rather than severe pathology, uncorrelated with epidemiological evidence of rising mental illness prevalence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the United States, youth antidepressant prescribing rates exceed those in Europe by approximately threefold, with no corresponding evidence of superior mental health outcomes or higher disorder incidence to justify the disparity. A comparative study found U.S. youth psychotropic medication prevalence at 6.7%, compared to 2.9% in the Netherlands and 2.0% in Germany, including antidepressants as a major component, suggesting over-reliance without proportional therapeutic gains.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup> This pattern persists, with U.S. youth showing 50% higher antidepressant use than European peers across recent years, fueling concerns that elevated rates stem from looser diagnostic thresholds rather than unmet need.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Empirical surveillance data further underscores unexplained prevalence jumps, as seen in Canada where primary care antidepressant prescribing rose from 9.2% in 2006 to 12.8% in 2012, without documented shifts in underlying depression epidemiology to account for the increase. Psychiatrists have cautioned against global over-reliance, noting that such escalations risk long-term dependency and side effects in cases where non-pharmacological interventions could suffice, based on evidence that many prescriptions target subthreshold symptoms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_74abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup></span>
<h3 id="pharma-influence-and-profit-motives" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pharma Influence and Profit Motives<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The expansion of selective serotonin reuptake inhibitor (SSRI) marketing following patent approvals in the late 1980s and intensified promotional efforts through the 1990s correlated with a marked rise in global antidepressant consumption after 2000. In OECD countries, defined daily doses per 1,000 inhabitants for antidepressants doubled from 2000 to 2017, driven in part by pharmaceutical campaigns emphasizing SSRI efficacy for broader indications. This period saw SSRI prescriptions surge in primary care settings, with U.S. visits involving antidepressants increasing from 2.6% in 1989 to 7.1% by 2000, a trend that persisted into the 2000s amid aggressive industry outreach to clinicians. Pharmaceutical revenues from antidepressants reflected these dynamics, with the global market valued at $14.93 billion in 2020 after years of growth fueled by such strategies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_75abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_95abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Consumption disparities across countries align with variations in profit-oriented marketing environments, notably higher in nations like the United States where direct-to-consumer advertising (DTCA) of pharmaceuticals has been permitted since 1997. DTCA for antidepressants has been shown to elevate usage by prompting patient requests that influence prescribing, with one analysis estimating up to a 10% increase from television exposure alone. In major depression cases, patient-driven requests for advertised drugs led to fulfillment rates exceeding 50% among physicians, prioritizing branded products over alternatives. Such mechanisms, absent or restricted in most other countries, underscore how industry incentives amplify demand in liberalized markets, contributing to the U.S. ranking among high-consumption nations despite comparable depression prevalence elsewhere.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_75qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_95qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Empirical patterns indicate that antidepressant utilization has advanced faster than verified increases in depression diagnoses, pointing to marketing-induced demand expansion over purely clinical imperatives. U.S. major depression prevalence rose from 3.3% in 1991â€“1992 to 7.1% in 2001â€“2002, yet by 2005â€“2008, antidepressants became the third-most-prescribed medication, affecting roughly 1 in 10 adultsâ€”a trajectory implying profit-driven broadening of treatment thresholds. Internationally, mean defined daily doses across studied countries climbed from 52.42 in 2010 to 69.5 by 2020, even as global depression estimates hovered around 5â€“6% of adults without equivalent surges. This divergence, documented in pharmacoepidemiologic reviews, reflects pharmaceutical efforts to frame milder symptoms as treatable conditions, prioritizing sales growthâ€”evident in sustained market expansion to over $20 billion by the mid-2020sâ€”over evidence of proportional therapeutic necessity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_56abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[72]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_76abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_96abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[74]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup></span>
<h3 id="cross-cultural-interpretations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cross-Cultural Interpretations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cross-national variations in antidepressant consumption have prompted debates over whether elevated rates in Western countries indicate heightened prevalence of clinical depression or the expansion of diagnostic criteria to encompass ordinary emotional suffering. Proponents of the medicalization hypothesis argue that Western biomedical frameworks pathologize adaptive responses to stress, such as grief or mild dysphoria, leading to higher prescribing without corresponding increases in severe pathology.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup> This view contrasts with interpretations favoring intrinsic cultural differences in psychopathology, where low consumption in regions like Asia reflects alternative expressions of distressâ€”often somatic rather than psychologicalâ€”rather than deficient detection.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In Asian contexts, antidepressant use remains notably subdued, with studies documenting lower utilization among Asian populations even when depression symptoms are comparable to Western norms, attributed to cultural preferences for non-pharmacological coping, including family support and traditional remedies, alongside persistent stigma against mental health labeling.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup> These patterns do not appear to signal undertreatment, as cross-cultural comparisons reveal no proportional deficits in overall functioning or resilience metrics; Eastern societies often exhibit lower reported anxiety and depression alongside adaptive social structures that mitigate distress without routine medication.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Critics of prevailing epidemic models question causal attributions linking low Eastern consumption to hidden morbidity, emphasizing instead that diagnostic fashions in the West amplify perceived disorder rates absent rigorous evidence of escalating true incidence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_58abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> Empirical data underscore cultural variance in symptom idiomâ€”physical complaints dominating in Asia versus cognitive-affective foci in the Westâ€”suggesting that global disparities owe more to interpretive lenses than universal pathology gradients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup> Such perspectives urge caution against assuming Western norms as benchmarks, highlighting how resilience-oriented Eastern approaches may avert unnecessary intervention without compromising well-being.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://ourworldindata.org/grapher/antidepressants-per-capita" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ourworldindata.org/grapher/antidepressants-per-capita" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ourworldindata.org/grapher/antidepressants-per-capita</a></span></div></li><li id="https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/</a></span></div></li><li id="https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country</a></span></div></li><li id="https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/</a></span></div></li><li id="https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12111178/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12111178/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12111178/</a></span></div></li><li id="https://www.who.int/tools/atc-ddd-toolkit/about-ddd" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/tools/atc-ddd-toolkit/about-ddd" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/tools/atc-ddd-toolkit/about-ddd</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10132527/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10132527/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10132527/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10071359/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10071359/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10071359/</a></span></div></li><li id="https://www.statista.com/topics/12402/depression-in-europe/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.statista.com/topics/12402/depression-in-europe/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.statista.com/topics/12402/depression-in-europe/</a></span></div></li><li id="https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/</a></span></div></li><li id="https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020</a></span></div></li><li id="https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00292-3/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00292-3/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00292-3/fulltext</a></span></div></li><li id="https://www.oecd.org/health/OECD-OBS-Launch-Country-Health-Profiles-2023.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.oecd.org/health/OECD-OBS-Launch-Country-Health-Profiles-2023.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.oecd.org/health/OECD-OBS-Launch-Country-Health-Profiles-2023.pdf</a></span></div></li><li id="https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-11" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-11</a></span></div></li><li id="https://www.voronoiapp.com/healthcare/The-Growing-Global-Reliance-on-Antidepressants-1183" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.voronoiapp.com/healthcare/The-Growing-Global-Reliance-on-Antidepressants-1183" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.voronoiapp.com/healthcare/The-Growing-Global-Reliance-on-Antidepressants-1183</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9766760/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9766760/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9766760/</a></span></div></li><li id="https://www.theguardian.com/society/2013/nov/20/antidepressant-use-rise-world-oecd" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.theguardian.com/society/2013/nov/20/antidepressant-use-rise-world-oecd" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.theguardian.com/society/2013/nov/20/antidepressant-use-rise-world-oecd</a></span></div></li><li id="https://www.bmj.com/content/347/bmj.f7261" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bmj.com/content/347/bmj.f7261" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bmj.com/content/347/bmj.f7261</a></span></div></li><li id="https://www.theguardian.com/news/2013/nov/20/mental-health-antidepressants-global-trends" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.theguardian.com/news/2013/nov/20/mental-health-antidepressants-global-trends" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.theguardian.com/news/2013/nov/20/mental-health-antidepressants-global-trends</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/40029558/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/40029558/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/40029558/</a></span></div></li><li id="https://link.springer.com/article/10.1007/s11126-025-10122-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s11126-025-10122-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s11126-025-10122-0</a></span></div></li><li id="https://www.publish.csiro.au/py/fulltext/PY23168" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.publish.csiro.au/py/fulltext/PY23168" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.publish.csiro.au/py/fulltext/PY23168</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/10.1155/2024/5448587" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/10.1155/2024/5448587" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/10.1155/2024/5448587</a></span></div></li><li id="https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/iqvia_2023_snapshot_antidepressants_2019-2022.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/iqvia_2023_snapshot_antidepressants_2019-2022.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/iqvia_2023_snapshot_antidepressants_2019-2022.pdf</a></span></div></li><li id="https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/snapshot-antidepressants-2024-en.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/snapshot-antidepressants-2024-en.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/snapshot-antidepressants-2024-en.pdf</a></span></div></li><li id="https://www.statista.com/statistics/782335/antidepressants-pharmaceutical-consumption-spain/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.statista.com/statistics/782335/antidepressants-pharmaceutical-consumption-spain/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.statista.com/statistics/782335/antidepressants-pharmaceutical-consumption-spain/</a></span></div></li><li id="https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70172" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70172" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70172</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9691511/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9691511/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9691511/</a></span></div></li><li id="https://link.springer.com/article/10.1007/s00127-025-02962-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://link.springer.com/article/10.1007/s00127-025-02962-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://link.springer.com/article/10.1007/s00127-025-02962-9</a></span></div></li><li id="https://academic.oup.com/fampra/article/42/2/cmae063/7905645" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/fampra/article/42/2/cmae063/7905645" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/fampra/article/42/2/cmae063/7905645</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6530307/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6530307/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6530307/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0165032722001392" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0165032722001392" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0165032722001392</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8969158/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8969158/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8969158/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6756318/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6756318/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6756318/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0161893820300880" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0161893820300880" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0161893820300880</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK44249/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK44249/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK44249/</a></span></div></li><li id="https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/antidepressant-use-in-27-european-countries-associations-with-sociodemographic-cultural-and-economic-factors/5AE6AFD0AC1D681AAE402F1B8D912AF3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/antidepressant-use-in-27-european-countries-associations-with-sociodemographic-cultural-and-economic-factors/5AE6AFD0AC1D681AAE402F1B8D912AF3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/antidepressant-use-in-27-european-countries-associations-with-sociodemographic-cultural-and-economic-factors/5AE6AFD0AC1D681AAE402F1B8D912AF3</a></span></div></li><li id="https://www.psychologytoday.com/us/blog/side-effects/201311/the-oecd-warns-antidepressant-overprescribing" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.psychologytoday.com/us/blog/side-effects/201311/the-oecd-warns-antidepressant-overprescribing" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.psychologytoday.com/us/blog/side-effects/201311/the-oecd-warns-antidepressant-overprescribing</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC1949440/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1949440/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC1949440/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/18817536/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/18817536/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/18817536/</a></span></div></li><li id="https://bmjopen.bmj.com/content/9/5/e027663" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmjopen.bmj.com/content/9/5/e027663" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmjopen.bmj.com/content/9/5/e027663</a></span></div></li><li id="https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0033-1357183?device=desktop&amp;innerWidth=412&amp;offsetWidth=396" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0033-1357183?device=desktop&amp;innerWidth=412&amp;offsetWidth=396" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0033-1357183?device=desktop&amp;innerWidth=412&amp;offsetWidth=396</a></span></div></li><li id="https://academic.oup.com/eurpub/article/31/2/291/6000721" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://academic.oup.com/eurpub/article/31/2/291/6000721" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://academic.oup.com/eurpub/article/31/2/291/6000721</a></span></div></li><li id="https://econtent.hogrefe.com/doi/10.1027/0227-5910/a000941" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://econtent.hogrefe.com/doi/10.1027/0227-5910/a000941" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://econtent.hogrefe.com/doi/10.1027/0227-5910/a000941</a></span></div></li><li id="https://www.researchgate.net/figure/Suicide-and-use-of-antidepressants-by-country-more-than-19-years-of-simultaneous-data_fig1_239730883" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.researchgate.net/figure/Suicide-and-use-of-antidepressants-by-country-more-than-19-years-of-simultaneous-data_fig1_239730883" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.researchgate.net/figure/Suicide-and-use-of-antidepressants-by-country-more-than-19-years-of-simultaneous-data_fig1_239730883</a></span></div></li><li id="https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-2</a></span></div></li><li id="https://www.nber.org/system/files/working_papers/w12906/w12906.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nber.org/system/files/working_papers/w12906/w12906.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nber.org/system/files/working_papers/w12906/w12906.pdf</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/24105079/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/24105079/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/24105079/</a></span></div></li><li id="https://www.europarl.europa.eu/RegData/etudes/BRIE/2023/751416/EPRS_BRI%282023%29751416_EN.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.europarl.europa.eu/RegData/etudes/BRIE/2023/751416/EPRS_BRI%282023%29751416_EN.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.europarl.europa.eu/RegData/etudes/BRIE/2023/751416/EPRS_BRI%282023%29751416_EN.pdf</a></span></div></li><li id="https://indianexpress.com/article/opinion/editorials/express-view-the-happiest-countries-also-rank-among-the-highest-in-antidepressant-consumption-8513372/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://indianexpress.com/article/opinion/editorials/express-view-the-happiest-countries-also-rank-among-the-highest-in-antidepressant-consumption-8513372/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://indianexpress.com/article/opinion/editorials/express-view-the-happiest-countries-also-rank-among-the-highest-in-antidepressant-consumption-8513372/</a></span></div></li><li id="https://www.worldhappiness.report/faq/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.worldhappiness.report/faq/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.worldhappiness.report/faq/</a></span></div></li><li id="https://www.npr.org/sections/health-shots/2024/03/20/1239537074/u-s-drops-in-new-global-happiness-ranking-one-age-group-bucks-the-trend" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.npr.org/sections/health-shots/2024/03/20/1239537074/u-s-drops-in-new-global-happiness-ranking-one-age-group-bucks-the-trend" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.npr.org/sections/health-shots/2024/03/20/1239537074/u-s-drops-in-new-global-happiness-ranking-one-age-group-bucks-the-trend</a></span></div></li><li id="https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0893-7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0893-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0893-7</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/18303940/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/18303940/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/18303940/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3712503/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3712503/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3712503/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/19526453/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/19526453/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/19526453/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2106356" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2106356" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2106356</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10594156/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10594156/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10594156/</a></span></div></li><li id="https://www.theguardian.com/society/2013/nov/21/prescribing-culture-blame-rise-antidepressants" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.theguardian.com/society/2013/nov/21/prescribing-culture-blame-rise-antidepressants" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.theguardian.com/society/2013/nov/21/prescribing-culture-blame-rise-antidepressants</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2569908/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2569908/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2569908/</a></span></div></li><li id="https://news.pharmacy.umaryland.edu/multinational-study-shows-increase-in-youth-antidepressant-use/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://news.pharmacy.umaryland.edu/multinational-study-shows-increase-in-youth-antidepressant-use/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://news.pharmacy.umaryland.edu/multinational-study-shows-increase-in-youth-antidepressant-use/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/26720825/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/26720825/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/26720825/</a></span></div></li><li id="https://www.bmj.com/content/348/bmj.g4218/rapid-responses" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bmj.com/content/348/bmj.g4218/rapid-responses" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.bmj.com/content/348/bmj.g4218/rapid-responses</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0048969722017491" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969722017491" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0048969722017491</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC419384/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC419384/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC419384/</a></span></div></li><li id="https://www.fortunebusinessinsights.com/antidepressants-market-105017" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.fortunebusinessinsights.com/antidepressants-market-105017" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.fortunebusinessinsights.com/antidepressants-market-105017</a></span></div></li><li id="https://jamanetwork.com/journals/jama/fullarticle/200780" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jamanetwork.com/journals/jama/fullarticle/200780" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jamanetwork.com/journals/jama/fullarticle/200780</a></span></div></li><li id="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1599" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1599" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1599</a></span></div></li><li id="https://www.kff.org/wp-content/uploads/2013/01/effects-of-direct-to-consumer-advertising-on-medication-choice-the-case-of-antidepressants.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.kff.org/wp-content/uploads/2013/01/effects-of-direct-to-consumer-advertising-on-medication-choice-the-case-of-antidepressants.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.kff.org/wp-content/uploads/2013/01/effects-of-direct-to-consumer-advertising-on-medication-choice-the-case-of-antidepressants.pdf</a></span></div></li><li id="https://psychiatryonline.org/doi/full/10.1176/pn.44.17.0008" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://psychiatryonline.org/doi/full/10.1176/pn.44.17.0008" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://psychiatryonline.org/doi/full/10.1176/pn.44.17.0008</a></span></div></li><li id="https://www.health.harvard.edu/blog/astounding-increase-in-antidepressant-use-by-americans-201110203624" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.health.harvard.edu/blog/astounding-increase-in-antidepressant-use-by-americans-201110203624" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.health.harvard.edu/blog/astounding-increase-in-antidepressant-use-by-americans-201110203624</a></span></div></li><li id="https://www.who.int/news-room/fact-sheets/detail/depression" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/news-room/fact-sheets/detail/depression" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/news-room/fact-sheets/detail/depression</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2475322/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2475322/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2475322/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10092833/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10092833/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10092833/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6534115/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6534115/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6534115/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2805045/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2805045/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2805045/</a></span></div></li><li id="https://www.psychologytoday.com/us/blog/talking-apes/201711/east-west-cultural-differences-in-depression" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.psychologytoday.com/us/blog/talking-apes/201711/east-west-cultural-differences-in-depression" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.psychologytoday.com/us/blog/talking-apes/201711/east-west-cultural-differences-in-depression</a></span></div></li><li id="https://www.nytimes.com/2010/01/10/magazine/10psyche-t.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nytimes.com/2010/01/10/magazine/10psyche-t.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nytimes.com/2010/01/10/magazine/10psyche-t.html</a></span></div></li><li id="https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.00574/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.00574/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.00574/full</a></span></div></li><li id="https://deconstructingstigma.org/guides/eastern-western-mh" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://deconstructingstigma.org/guides/eastern-western-mh" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://deconstructingstigma.org/guides/eastern-western-mh</a></span></div></li></ol></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2" id="_R_" async=""></script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"List_of_countries_by_antidepressant_consumption\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"List_of_countries_by_antidepressant_consumption\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"List_of_countries_by_antidepressant_consumption\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:Tbee9,"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"# List of countries by antidepressant consumption\n\n![Iceland flag](./_assets_/Flag_of_Iceland.svg.png)\nA list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization's defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability.[](https://ourworldindata.org/grapher/antidepressants-per-capita) This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest rate at 157 DDD per 1,000 inhabitants per day in recent assessments, followed closely by Portugal, Canada, Australia, and Sweden.[](https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/)[](https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country) Overall OECD consumption of these drugs escalated by approximately 50% between 2011 and 2021, a trend amplified in countries such as Chile and South Korea where it more than doubled, amid rising mental disorder prevalence estimates affecting one in six Europeans.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) Such disparities fuel inquiries into causal factors including healthcare access, diagnostic expansion, and potential overprescription, particularly in affluent nations where usage correlates imperfectly with self-reported happiness or suicide rates, suggesting influences beyond raw pathology like cultural attitudes toward pharmacotherapy.[](https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12111178/)\n\n## Data Sources and Methodology\n\n### OECD Standardized Metrics\n\n![Flag of Iceland](./_assets_/Flag_of_Iceland.svg.png)\nThe OECD employs the defined daily dose (DDD) per 1,000 inhabitants per day as the primary metric for standardizing antidepressant consumption, a system defined by the World Health Organization (WHO) as the assumed average maintenance dose per day for a drug's main indication in adults.[](https://www.who.int/tools/atc-ddd-toolkit/about-ddd) This measure, applied to antidepressants under the Anatomical Therapeutic Chemical (ATC) classification code N06Aâ€”which encompasses selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and other agentsâ€”facilitates empirical cross-country comparability by accounting for differences in dosing assumptions rather than raw sales or prescriptions.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\nBy converting wholesale, distribution, or reimbursement data into DDD equivalents, the methodology minimizes distortions from varying national prescribing patterns, generic availability, or over-the-counter access, yielding a consistent indicator of population-level utilization.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) OECD data, harmonized for 38 member countries where available, cover periods up to 2020-2022 depending on national reporting, with the aggregate average rising from 52.4 DDD per 1,000 inhabitants per day in 2010 to 69.5 in 2020.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/)\n\nNotable variations within this framework include Iceland's consumption surpassing 100 DDD, reaching 153 in 2020 assessments, and Portugal's at 131 DDD, underscoring the metric's capacity to reveal disparities while maintaining standardization.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) These figures derive from aggregated pharmaceutical distribution records, ensuring reliance on verifiable wholesale quantities adjusted for population demographics.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\n### Alternative Datasets and Limitations\n\nIn addition to OECD data, alternative datasets on antidepressant consumption include those derived from the World Health Organization's (WHO) Anatomical Therapeutic Chemical (ATC) classification system, which standardizes defined daily doses (DDD) per 1,000 inhabitants per day across broader global samples, though with varying national reporting quality.[](https://ourworldindata.org/grapher/antidepressants-per-capita) Our World in Data aggregates such WHO-sourced figures, enabling cross-country comparisons but relying on voluntary submissions that often exclude low-reporting regions.[](https://ourworldindata.org/grapher/antidepressants-per-capita) Private sector analyses, such as IQVIA's Multinational Integrated Data Analysis System (MIDAS), track pharmaceutical sales volumes from 2014 onward across up to 65 countries, providing granular wholesaler and retail data adjusted for population but limited to commercial markets.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10132527/)\n\nMethodological variances arise in coverage and granularity; for instance, World Population Review compiles 2016â€“2020 averages from diverse sources including national registries, extending to non-OECD nations like Serbia where OECD data is absent, yet these aggregates may incorporate less standardized imputation for gaps, leading to potential divergences from OECD's pharmacy-dispensed DDD metrics focused on high-income members.[](https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country) National registries, such as those in Nordic countries via administrative health databases, offer high-fidelity outpatient prescription records but emphasize domestic rather than comparative metrics, differing from OECD's harmonized international benchmarking.00292-3.pdf) Emphasis across these sources remains on population-adjusted DDD over raw volumes to account for demographic scale, though discrepancies persist due to differing inclusion of generics or formulation variants.\n\nKey limitations include systemic underreporting in low- and middle-income countries (LMICs), where data scarcity stems from fragmented pharmacovigilance and limited electronic health systems, resulting in prevalence estimates 2â€“4 times lower than in high-income settings despite comparable mental health burdens.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10071359/) Most datasets prioritize outpatient dispensing or sales, often omitting inpatient hospital administrations which can constitute 10â€“20% of total use in acute settings.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html) Over-the-counter or informal black-market consumption is excluded entirely, as antidepressants are strictly prescription-controlled in monitored jurisdictions, potentially understating actual intake in regions with weak regulatory enforcement.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10132527/) These gaps underscore the need for triangulating multiple verifiable sources to mitigate biases toward well-documented high-income data.\n\n## Current Global Rankings\n\n### Highest Consumption Countries\n\nIceland consistently ranks as the country with the highest antidepressant consumption, recording 157.3 defined daily doses (DDD) per 1,000 inhabitants per day in 2022.[](https://www.statista.com/topics/12402/depression-in-europe/) Portugal follows closely, with consumption reaching 154.4 DDD per 1,000 inhabitants per day in 2023.[](https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/) These figures reflect standardized OECD metrics for pharmaceutical use, focusing on ATC code N06A drugs.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\nAnalyses of OECD data from 2016 to 2020 identify Iceland, Portugal, Canada, Australia, and Sweden as the top consumers overall.[](https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country) A comparative study of 30 OECD countries up to 2020 reported Iceland at 153 DDD and Portugal at 131 DDD, underscoring sustained high levels in these nations.[](https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020)\n\n| Country   | DDD per 1,000 inhabitants/day | Year |\n|-----------|-------------------------------|------|\n| Iceland  | 157.3                        | 2022 |[](https://www.statista.com/topics/12402/depression-in-europe/)\n| Portugal | 154.4                        | 2023 |[](https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/)\n| Iceland  | 153                          | 2020 |[](https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020)\n| Portugal | 131                          | 2020 |[](https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020)\n\n![Flag of Iceland](./_assets_/Flag_of_Iceland.svg.png)\n\n### Lowest Consumption Countries\n\nCountries exhibiting the lowest levels of antidepressant consumption, as measured by defined daily doses (DDD) per 1,000 inhabitants per day, stand in stark contrast to higher-use nations, with rates often below 50 DDD compared to the OECD average of approximately 70 DDD in 2020.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) Latvia recorded 20 DDD in 2020, the lowest among European OECD countries analyzed.[](https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants) South Korea maintained relatively low usage at 31.1 DDD in recent data, despite a doubling of consumption from prior baselines between 2011 and 2021.[](https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/)[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html) Turkey reported 49 DDD in 2020, below the OECD mean, reflecting patterns in larger emerging economies within the organization.[](https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants)\n\nThese figures, derived primarily from OECD pharmaceutical sales and prescription data, indicate stability or modest growth in low-consumption countries over the 2010-2020 period, contrasting with steeper rises elsewhere.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) For instance, while the OECD-wide mean climbed from 52.4 DDD in 2010 to 69.5 DDD in 2020, low-use nations like those listed showed linear or concave trends with annual increases under 2 DDD on average.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) Such disparities challenge uniform narratives of mental health treatment needs, as DDD metrics capture prescribed volumes rather than diagnosed prevalence or self-reported distress, potentially influenced by cultural stigma, alternative coping mechanisms, or diagnostic practices.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) Data limitations include incomplete coverage for non-OECD nations like Mexico, where consumption is presumed low based on regional patterns in Latin America but lacks standardized DDD reporting.[](https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00292-3/fulltext)\n\nThe following table summarizes select lowest-consumption OECD countries for context against the average:\n\n| Country     | DDD per 1,000 Inhabitants per Day | Year | Relative to OECD Average |\n|-------------|-----------------------------------|------|--------------------------|\n| Latvia     | 20                               | 2020 | ~29%                    |\n| South Korea| 31.1                             | ~2022| ~44%                    |\n| Turkey     | 49                               | 2020 | ~70%                    |\n\nOECD average: ~70 DDD (2020).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/)[](https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants)[](https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/)\n\n![Flag of Turkey](./_assets_/Flag_of_Turkey.svg.png)\n\nThese patterns persist despite global pressures like the COVID-19 pandemic, which prompted increases across most OECD members but proportionally less in low-baseline countries, underscoring variability in prescribing responses.[](https://www.oecd.org/health/OECD-OBS-Launch-Country-Health-Profiles-2023.pdf) Empirical evidence does not conclusively link low DDD to adverse outcomes, as cross-national suicide rates and well-being metrics vary independently; for example, South Korea's high suicide rate coexists with low antidepressant use, potentially tied to other factors like economic stress rather than pharmacological underutilization.[](https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-11) Source credibility in such data relies on standardized OECD methodologies, though extensions to non-members introduce estimation errors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/)\n\n### Regional Patterns\n\nIn Europe, antidepressant consumption exhibits elevated and variable patterns, with Northern countries such as Iceland and Sweden among the global leaders at rates exceeding 100 defined daily doses (DDD) per 1,000 inhabitants per day in recent OECD assessments, while Southern Europe includes outliers like Portugal with comparably high utilization around 120 DDD per 1,000.[](https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country)[](https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/) Across 18 European nations, the regional average rose from 30.5 DDD per 1,000 in 2000 to 75.3 DDD per 1,000 in 2020, though exceptions like Denmark show rare instances of stagnation or decline amid broader increases.[](https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants)\n\nNorth America displays consistently high consumption, driven by rates in Canada and the United States surpassing 80 DDD per 1,000 inhabitants per day in OECD-tracked data through 2021, positioning the region alongside Europe and Oceania as a cluster of peak utilization.[](https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country)[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\nIn contrast, Asia and Africa feature generally low consumption levels, with Asian OECD members like South Korea recording under 35 DDD per 1,000 despite recent doublings, and African data remaining sparse due to limited pharmaceutical tracking, implying rates far below global highs based on available WHO and IQVIA aggregates.[](https://www.voronoiapp.com/healthcare/The-Growing-Global-Reliance-on-Antidepressants-1183)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9766760/) Latin America shows emerging but subdued patterns, exemplified by Chile's tripling to moderate levels over the 2010s, yet still trailing high-income regions.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\n## Historical and Temporal Trends\n\n### Increases Since 2000\n\nAntidepressant consumption, measured in defined daily doses (DDD) per 1,000 inhabitants per day, has exhibited consistent upward trends across OECD countries since 2000. Analyses of OECD data indicate that consumption increased in every examined member country between 2000 and 2011, with an overall rise of approximately 65% across 34 nations during this period.[](https://www.theguardian.com/society/2013/nov/20/antidepressant-use-rise-world-oecd) This baseline expansion established a foundation for subsequent growth, reflecting broader adoption of these medications in primary care and outpatient settings.[](https://www.bmj.com/content/347/bmj.f7261)\n\nIn a subset of 18 European OECD countries, average consumption rose from 30.5 DDD per 1,000 inhabitants per day in 2000 to 75.3 DDD by 2020, more than doubling over two decades.[](https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants) Country-specific data from the early period highlight varied but uniformly positive increments; for instance, Iceland's consumption climbed from 71 DDD in 2000 to 130 DDD in 2011, while Australia's increased from 45 DDD to 89 DDD.[](https://www.bmj.com/content/347/bmj.f7261) The following table summarizes decade-over-decade changes for select OECD countries based on available standardized metrics:\n\n| Country    | 2000 DDD | 2011 DDD | % Increase (2000-2011) |\n|------------|----------|----------|------------------------|\n| Iceland   | 71      | 130     | 83%                   |\n| Australia | 45      | 89      | 98%                   |\n| Canada    | ~40     | ~67     | 68%                   |\n| United Kingdom | ~30 | ~54     | 80%                   |\n\nThese figures, derived from OECD pharmaceutical sales data adjusted for population, underscore the pervasive nature of the rise without exception in the sampled jurisdictions.[](https://www.theguardian.com/news/2013/nov/20/mental-health-antidepressants-global-trends) By the mid-2010s, the trajectory had begun to accelerate in many regions, setting the stage for further elevations into the 2020s, though baseline patterns originated in the post-2000 era.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\n### Post-2010 Accelerations\n\nFrom 2010 to 2020, the average antidepressant consumption across 30 OECD countries rose from 52.42 defined daily doses (DDD) per 1,000 inhabitants per day to 69.5 DDD, marking a period of accelerated growth beyond prior trends.[](https://pubmed.ncbi.nlm.nih.gov/40029558/) This increase, equivalent to nearly a 33% rise over the decade, was evident in the majority of analyzed nations, with annual increments averaging 1.68 DDD per 1,000 inhabitants.[](https://link.springer.com/article/10.1007/s11126-025-10122-0) Trend analyses identified linear upward trajectories in most cases, alongside concave patterns indicating initial slower growth followed by steeper rises, and convex patterns with early surges tapering later.[](https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020)\n\nNotable accelerations occurred in specific countries, including Australia, where consumption reached 106.7 DDD per 1,000 inhabitants by 2016, reflecting a sharp escalation from earlier baselines.[](https://www.publish.csiro.au/py/fulltext/PY23168) In Portugal, antidepressant use surged, with defined daily doses increasing by over 15 DDD per 1,000 inhabitants per day by the early 2020s, building on post-2010 momentum driven by expanded access and prescribing.[](https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/) Sweden similarly saw heightened usage, with prevalence rates climbing from 78 to 107 users per 1,000 inhabitants between 2006 and 2021, aligning with DDD trends emphasizing sustained post-2010 expansion in Nordic contexts.[](https://onlinelibrary.wiley.com/doi/10.1155/2024/5448587) These patterns were underpinned by the growing dominance of selective serotonin reuptake inhibitors (SSRIs), which accounted for the bulk of incremental prescriptions across OECD datasets.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\nOverall, the decade post-2010 demonstrated empirically verifiable sharpening in consumption trajectories, with OECD-wide data confirming broad-based growth rather than isolated anomalies.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/) This period's dynamics highlighted a convergence toward higher utilization norms, particularly in Western Europe and Anglosphere nations, as captured in standardized DDD metrics.[](https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants)\n\n### Pandemic-Era Shifts\n\nIn Canada, antidepressant dispensing volumes rose substantially during the pandemic period, with over 2.5 billion units dispensed nationwide in 2022 alone, marking a 19.5% increase from 2019 levels.[](https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/iqvia_2023_snapshot_antidepressants_2019-2022.pdf) Between 2019 and 2023, prevalence rates increased across all provinces except Ontario, driven by higher utilization in younger age groups under 65; the Atlantic provinces exhibited the highest per capita rates in 2023.[](https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/snapshot-antidepressants-2024-en.pdf)\n\nEuropean countries displayed heterogeneous patterns in outpatient antidepressant dispensing from 2020 to 2023, with accelerations in several nations amid the pandemic. Portugal recorded a sharp rise, with consumption climbing by 15.6 defined daily doses (DDD) per 1,000 inhabitants per day in 2023 relative to 2022.[](https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/) Spain saw a comparable uptick of 5.7 DDD per 1,000 in 2022 over the previous year, reflecting sustained growth into the post-acute phase.[](https://www.statista.com/statistics/782335/antidepressants-pharmaceutical-consumption-spain/) Sweden maintained elevated prevalence, with user rates per 1,000 inhabitants advancing from 107 in earlier pandemic years through 2021, outpacing Nordic peers.[](https://onlinelibrary.wiley.com/doi/10.1155/2024/5448587)\n\nOutliers emerged where pre-pandemic downward trajectories stabilized or moderated. In Denmark, incident antidepressant use, which had declined prior to 2020, leveled off or slowed during and after the pandemic, contrasting broader regional increases of 13.5% to 31.3% in filled prescriptions by late 2020.[](https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70172)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9691511/) These shifts coincided with policy adaptations like expanded telehealth but did not uniformly correlate with infection rates or lockdown stringency across datasets up to 2023.[](https://link.springer.com/article/10.1007/s00127-025-02962-9)\n\n## Determinants of Variation\n\n### Healthcare Access and Prescribing Practices\n\nCountries with universal healthcare coverage, particularly in the Nordic region, demonstrate elevated antidepressant consumption due to reduced financial and logistical barriers to primary care consultations and prescriptions. In Norway, for example, the national health system provides comprehensive coverage for general practitioner visits, enabling widespread access to mental health evaluations and pharmacotherapy without out-of-pocket costs deterring uptake.[](https://academic.oup.com/fampra/article/42/2/cmae063/7905645) This contrasts with lower-consumption regions featuring fragmented or under-resourced systems, where limited reimbursement and provider shortages restrict prescribing volume; OECD data across member states show antidepressant use rising 50% from 2011 to 2021 in high-access environments, outpacing gains in less integrated systems.[](https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html)\n\nPrescribing practices vary by drug class, with a shift toward selective serotonin reuptake inhibitors (SSRIs) in outpatient-oriented systems correlating to higher overall consumption, as these agents are favored for their tolerability and ease of initiation in primary care. Multinational analyses reveal SSRIs dominating new prescriptions in older adults across Europe, comprising the majority of antidepressant initiations in countries emphasizing ambulatory care over inpatient treatment.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6530307/) In contrast, older tricyclic antidepressants persist in select settings with inpatient focus or regulatory preferences, but their lower prevalence in accessible outpatient models contributes to disparities; for instance, European utilization studies document SSRI shares exceeding 70% of total antidepressant defined daily doses in nations like the Netherlands and Sweden.[](https://www.sciencedirect.com/science/article/pii/S0165032722001392)\n\nEmpirical evidence from European cohorts links physical disability and comorbid health conditions to increased antidepressant prescriptions, independent of mental health diagnoses alone, as providers address overlapping symptoms through pharmacotherapy. A repetitive cross-sectional analysis across 19 European countries found individuals with physical disabilities were more likely to receive antidepressants in 13 nations, attributing this to integrated care pathways where disability assessments prompt broader prescribing.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8969158/) Similarly, studies on transitions to disability pensions show heightened prescription rates preceding awards for conditions like back pain, reflecting practitioner incentives tied to holistic symptom management under public reimbursement frameworks.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6756318/) These patterns underscore how systemic access amplifies prescribing for disability-related indications, driving consumption variances without implying diagnostic overreach.\n\n### Economic and Cultural Influences\n\nA positive correlation exists between gross domestic product (GDP) per capita and antidepressant consumption across European countries. Analysis of selective serotonin reuptake inhibitor (SSRI) use in 13 European nations in 2019 revealed a Spearman's rank correlation coefficient of Ï = 0.714 (p = 0.0081), indicating that wealthier economies tend to exhibit higher per capita consumption rates.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12111178/) This pattern extends to broader OECD data, where elevated GDP per capita stimulates overall antidepressant demand, potentially reflecting greater affordability and integration of pharmacotherapy into routine care.[](https://www.sciencedirect.com/science/article/abs/pii/S0161893820300880) Such associations suggest economic capacity enables expanded prescribing, though they do not imply proportional increases in underlying disorder prevalence.\n\nCultural attitudes toward mental illness significantly influence consumption disparities. In Asia, pervasive stigma frames psychiatric conditions as familial dishonor, deterring help-seeking and pharmacotherapy; for instance, affected individuals face diminished marriage prospects and economic opportunities, fostering underreporting and avoidance of antidepressants.[](https://www.ncbi.nlm.nih.gov/books/NBK44249/) This contrasts with Europe, where variations in public perceptionsâ€”such as acceptance of biomedical explanations for depressionâ€”partly account for prescribing differences across 27 countries, despite comparable affective disorder prevalence.[](https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/antidepressant-use-in-27-european-countries-associations-with-sociodemographic-cultural-and-economic-factors/5AE6AFD0AC1D681AAE402F1B8D912AF3) Empirical evidence indicates these contextual factors drive utilization gaps beyond clinical necessities, as antidepressant uptake correlates more strongly with societal norms than with uniform diagnostic rates.[](https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/antidepressant-use-in-27-european-countries-associations-with-sociodemographic-cultural-and-economic-factors/5AE6AFD0AC1D681AAE402F1B8D912AF3)[](https://www.sciencedirect.com/science/article/abs/pii/S0161893820300880)\n\n### Diagnostic and Regulatory Factors\n\nVariations in antidepressant consumption across countries are influenced by differences in diagnostic practices, where expansions in criteria or heightened awareness have not always aligned with empirical increases in severe cases. A 2013 OECD analysis of member states revealed that antidepressant use had risen sharplyâ€”doubling or tripling in many nations over the prior decadeâ€”yet this growth was not matched by proportional increases in diagnosed depression prevalence, prompting concerns over diagnostic inflation and off-label prescribing for milder symptoms.[](https://www.theguardian.com/society/2013/nov/20/antidepressant-use-rise-world-oecd)[](https://www.psychologytoday.com/us/blog/side-effects/201311/the-oecd-warns-antidepressant-overprescribing) Empirical studies support mismatches, with meta-analyses indicating that placebo response rates in depression trials (often exceeding 30%) suggest many cases labeled as major depressive disorder may remit without intervention, implying overdiagnosis in broader diagnostic nets.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC1949440/)\n\nEvidence of overdiagnosis is particularly evident in pediatric populations, where psychotropic medication prevalence highlights transatlantic disparities. A 2008 comparative study across healthcare systems found the annual rate of any psychotropic use among youth aged 0-18 was 6.7% in the United States, compared to 2.9% in the Netherlands and 2.0% in Germany, despite similar underlying mental health burdens; this gap persists amid critiques that U.S. diagnostic thresholds for conditions like ADHD and depression are lower, leading to higher antidepressant initiation without commensurate severity.[](https://pubmed.ncbi.nlm.nih.gov/18817536/) Such patterns underscore how diagnostic expansionsâ€”often driven by guideline updates favoring pharmacological interventionâ€”can inflate consumption independent of true epidemiological shifts.\n\nRegulatory frameworks further modulate access and prescribing thresholds, with Western nations generally permitting broader indications than in regions with stricter oversight. In the United States, antidepressants like fluoxetine received FDA approval for pediatric depression in 2002 following controlled trials, facilitating prescriptions despite subsequent black-box warnings on suicidality risks, whereas European Medicines Agency (EMA) restrictions in several countries limit approvals for under-18s to severe cases only, correlating with lower youth utilization rates.[](https://pubmed.ncbi.nlm.nih.gov/18817536/) Countries like the United Kingdom, adhering to conservative National Institute for Health and Care Excellence (NICE) guidelines that prioritize psychotherapy for mild-to-moderate depression, exhibit among the lowest per-capita consumption in older adults, illustrating how regulatory conservatism curbs volume compared to more permissive U.S. practices.[](https://bmjopen.bmj.com/content/9/5/e027663) These differences persist despite harmonized pharmacovigilance, as national agencies tailor approvals to local evidence thresholds and cost-benefit analyses.\n\n## Associations with Outcomes\n\n### Links to Suicide and Mortality Rates\n\n![Flag of Iceland](./_assets_/Flag_of_Iceland.svg.png)\nEmpirical studies examining national-level data on antidepressant consumption and suicide rates have yielded mixed results, with no robust evidence of a strong negative correlation. A analysis of OECD countries identified a statistically significant but weak association between antidepressant prescribing rates and suicide rates, suggesting limited explanatory power for consumption in reducing suicides.[](https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0033-1357183?device=desktop\u0026innerWidth=412\u0026offsetWidth=396) Similarly, an ecological study across European nations found no association between the introduction and increased prescribing of antidepressants and subsequent declines in suicide rates.[](https://academic.oup.com/eurpub/article/31/2/291/6000721)\n\nIn the United States, antidepressant prescription prevalence rose alongside suicide rates from 1990 to 2020, indicating persistence of suicides despite expanded access to these medications.[](https://econtent.hogrefe.com/doi/10.1027/0227-5910/a000941) High-consumption countries like Iceland, with 141.4 defined daily doses (DDD) per 1,000 inhabitants in 2017, and Portugal, at 103.6 DDD, do not exhibit proportionally low suicide rates; Portugal, in particular, shows a positive correlation between antidepressant utilization and standardized suicide death rates.[](https://www.researchgate.net/figure/Suicide-and-use-of-antidepressants-by-country-more-than-19-years-of-simultaneous-data_fig1_239730883) Low-consumption nations display variable suicide outcomes, with some like South Korea experiencing elevated rates despite minimal use, underscoring multifactorial influences beyond pharmacotherapy.[](https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-2)\n\nRegarding overall mortality, population-level data linking antidepressant consumption to reduced all-cause deaths are scarce, while critiques highlight potential long-term risks such as treatment dependency and withdrawal effects that could elevate vulnerability to adverse health outcomes.[](https://www.nber.org/system/files/working_papers/w12906/w12906.pdf) These patterns challenge assumptions of straightforward efficacy at the societal scale, as confounders including economic factors, healthcare access, and diagnostic practices likely mediate observed variations.[](https://pubmed.ncbi.nlm.nih.gov/24105079/)\n\n### Correlations with Self-Reported Mental Health\n\n![Flag of Iceland](./_assets_/Flag_of_Iceland.svg.png)\nIn Europe, mental health conditions affect approximately one in six individuals, with around 84 million people impacted as of 2019, encompassing disorders such as depression and anxiety.[](https://www.europarl.europa.eu/RegData/etudes/BRIE/2023/751416/EPRS_BRI%282023%29751416_EN.pdf) However, antidepressant consumption rates exhibit substantial variation across European Union member states, ranging from highs in Nordic countries like Iceland and Sweden to lower levels elsewhere, without a direct proportional alignment to self-reported prevalence of depressive symptoms.00061-8/fulltext) A 2022 cross-sectional analysis across 19 European countries found that while antidepressant usage among those reporting depressive symptoms has risen, with prevalence increasing from 36.5% to 50.0% between waves, inter-country and subgroup differences persist independently of symptom severity, indicating influences such as socioeconomic factors and healthcare access beyond raw incidence.00061-8/fulltext)\n\nNordic nations exemplify discrepancies between high antidepressant consumption and favorable self-reported well-being metrics. Iceland leads globally in per capita antidepressant use, yet consistently ranks among the top in the World Happiness Report's life evaluation scores, alongside Denmark, Finland, and Sweden, which also feature elevated consumption ratesâ€”Finland, for instance, reported 81 daily defined doses per 1,000 inhabitants in recent OECD dataâ€”while maintaining high self-assessed happiness levels as of 2024 rankings.[](https://indianexpress.com/article/opinion/editorials/express-view-the-happiest-countries-also-rank-among-the-highest-in-antidepressant-consumption-8513372/)  These patterns suggest that increased labeling or willingness to medically address milder symptoms, rather than elevated underlying distress, may drive usage in environments with robust mental health awareness and access.[](https://www.worldhappiness.report/faq/)\n\nIn contrast, the United States exhibits high antidepressant consumptionâ€”around 17% of adults used such medications in recent surveysâ€”paired with middling self-reported mental health outcomes, including a decline to 23rd in global happiness rankings by 2024, where younger cohorts report notably lower life satisfaction than older groups.[](https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country) [](https://www.npr.org/sections/health-shots/2024/03/20/1239537074/u-s-drops-in-new-global-happiness-ranking-one-age-group-bucks-the-trend) European studies further reveal that self-reported poor mental health correlates with higher prescription redemption probabilities, yet aggregate country-level data show only partial positive associations, with cultural and diagnostic practices modulating the link.[](https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0893-7) 00061-8/fulltext) Such variances imply that self-reported metrics capture subjective perceptions influenced by societal norms on symptom acknowledgment, rather than purely objective disease burden.[](https://www.worldhappiness.report/faq/)\n\n### Evidence on Treatment Effectiveness\n\nMeta-analyses of randomized controlled trials demonstrate that antidepressants yield modest symptom reduction in major depressive disorder compared to placebo, with standardized mean differences typically ranging from 0.30 to 0.50. A 2018 network meta-analysis encompassing 522 double-blind RCTs involving over 116,000 participants concluded that all 21 antidepressants examined outperformed placebo in acute treatment, though head-to-head differences among agents were small and acceptability varied.32802-7/fulltext) Effect sizes, however, depend on depression severity: benefits are negligible or absent in mild cases, where placebo responses are high, but increase modestly in moderate to severe depression, with drug-placebo differences remaining limited even among severely ill patients.[](https://pubmed.ncbi.nlm.nih.gov/18303940/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3712503/)\n\nLong-term maintenance trials reveal elevated relapse risks upon discontinuation, underscoring potential causal dependence on continued pharmacotherapy. Across 11 studies, one-year relapse rates were 23% for active antidepressant versus 51% for placebo.[](https://pubmed.ncbi.nlm.nih.gov/19526453/) A 2021 primary care RCT of 478 patients in remission reported cumulative relapse incidences of 39% in the maintenance group and 56% in the discontinuation group by 52 weeks, with a hazard ratio of 1.61 favoring continuation.[](https://www.nejm.org/doi/full/10.1056/NEJMoa2106356) These findings from placebo-controlled designs suggest short-term gains may not translate to sustained remission without ongoing treatment, though absolute relapse prevention diminishes over time.\n\nCross-nationally, elevated antidepressant consumption shows no consistent association with superior population-level mental health outcomes, challenging assumptions of broad causal efficacy. An analysis of country-level data found that rises in antidepressant prescribing from 2000 to 2019 correlated neither with reduced prevalence of sadness symptoms nor with lower depressive disorder rates, despite marked increases in use in high-consuming nations.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10594156/) Similarly, a 2022 European study across 19 countries observed that higher usage among those with depressive symptoms aligned with fewer psychiatric beds per capita but yielded no improvements in self-reported mental health metrics or suicide rates.00061-8/fulltext) Such patterns imply that pharmacological expansion may address symptoms selectively rather than driving systemic recovery, particularly where diagnostic expansion precedes consumption surges.\n\n## Debates and Critiques\n\n### Overprescription Concerns\n\nRising antidepressant consumption across OECD countries has raised alarms about overprescription, as usage surges have not been accompanied by proportional increases in diagnosed depression rates. A 2013 OECD analysis highlighted that antidepressant consumption doubled or more in several nations between 2000 and 2011, prompting fears of overuse driven by factors beyond clinical necessity, such as expanded indications for milder symptoms.[](https://www.theguardian.com/society/2013/nov/20/antidepressant-use-rise-world-oecd) European psychiatrists have warned that this trend reflects a \"medicalisation of misery,\" with prescribing pressures leading to antidepressants being issued for transient unhappiness rather than severe pathology, uncorrelated with epidemiological evidence of rising mental illness prevalence.[](https://www.theguardian.com/society/2013/nov/21/prescribing-culture-blame-rise-antidepressants)\n\nIn the United States, youth antidepressant prescribing rates exceed those in Europe by approximately threefold, with no corresponding evidence of superior mental health outcomes or higher disorder incidence to justify the disparity. A comparative study found U.S. youth psychotropic medication prevalence at 6.7%, compared to 2.9% in the Netherlands and 2.0% in Germany, including antidepressants as a major component, suggesting over-reliance without proportional therapeutic gains.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2569908/) This pattern persists, with U.S. youth showing 50% higher antidepressant use than European peers across recent years, fueling concerns that elevated rates stem from looser diagnostic thresholds rather than unmet need.[](https://news.pharmacy.umaryland.edu/multinational-study-shows-increase-in-youth-antidepressant-use/)\n\nEmpirical surveillance data further underscores unexplained prevalence jumps, as seen in Canada where primary care antidepressant prescribing rose from 9.2% in 2006 to 12.8% in 2012, without documented shifts in underlying depression epidemiology to account for the increase. Psychiatrists have cautioned against global over-reliance, noting that such escalations risk long-term dependency and side effects in cases where non-pharmacological interventions could suffice, based on evidence that many prescriptions target subthreshold symptoms.[](https://pubmed.ncbi.nlm.nih.gov/26720825/)[](https://www.bmj.com/content/348/bmj.g4218/rapid-responses)\n\n### Pharma Influence and Profit Motives\n\nThe expansion of selective serotonin reuptake inhibitor (SSRI) marketing following patent approvals in the late 1980s and intensified promotional efforts through the 1990s correlated with a marked rise in global antidepressant consumption after 2000. In OECD countries, defined daily doses per 1,000 inhabitants for antidepressants doubled from 2000 to 2017, driven in part by pharmaceutical campaigns emphasizing SSRI efficacy for broader indications. This period saw SSRI prescriptions surge in primary care settings, with U.S. visits involving antidepressants increasing from 2.6% in 1989 to 7.1% by 2000, a trend that persisted into the 2000s amid aggressive industry outreach to clinicians. Pharmaceutical revenues from antidepressants reflected these dynamics, with the global market valued at $14.93 billion in 2020 after years of growth fueled by such strategies.[](https://www.sciencedirect.com/science/article/abs/pii/S0048969722017491)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC419384/)[](https://www.fortunebusinessinsights.com/antidepressants-market-105017)\n\nConsumption disparities across countries align with variations in profit-oriented marketing environments, notably higher in nations like the United States where direct-to-consumer advertising (DTCA) of pharmaceuticals has been permitted since 1997. DTCA for antidepressants has been shown to elevate usage by prompting patient requests that influence prescribing, with one analysis estimating up to a 10% increase from television exposure alone. In major depression cases, patient-driven requests for advertised drugs led to fulfillment rates exceeding 50% among physicians, prioritizing branded products over alternatives. Such mechanisms, absent or restricted in most other countries, underscore how industry incentives amplify demand in liberalized markets, contributing to the U.S. ranking among high-consumption nations despite comparable depression prevalence elsewhere.[](https://jamanetwork.com/journals/jama/fullarticle/200780)[](https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1599)[](https://www.kff.org/wp-content/uploads/2013/01/effects-of-direct-to-consumer-advertising-on-medication-choice-the-case-of-antidepressants.pdf)\n\nEmpirical patterns indicate that antidepressant utilization has advanced faster than verified increases in depression diagnoses, pointing to marketing-induced demand expansion over purely clinical imperatives. U.S. major depression prevalence rose from 3.3% in 1991â€“1992 to 7.1% in 2001â€“2002, yet by 2005â€“2008, antidepressants became the third-most-prescribed medication, affecting roughly 1 in 10 adultsâ€”a trajectory implying profit-driven broadening of treatment thresholds. Internationally, mean defined daily doses across studied countries climbed from 52.42 in 2010 to 69.5 by 2020, even as global depression estimates hovered around 5â€“6% of adults without equivalent surges. This divergence, documented in pharmacoepidemiologic reviews, reflects pharmaceutical efforts to frame milder symptoms as treatable conditions, prioritizing sales growthâ€”evident in sustained market expansion to over $20 billion by the mid-2020sâ€”over evidence of proportional therapeutic necessity.[](https://psychiatryonline.org/doi/full/10.1176/pn.44.17.0008)[](https://www.health.harvard.edu/blog/astounding-increase-in-antidepressant-use-by-americans-201110203624)[](https://www.who.int/news-room/fact-sheets/detail/depression)[](https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020)\n\n### Cross-Cultural Interpretations\n\nCross-national variations in antidepressant consumption have prompted debates over whether elevated rates in Western countries indicate heightened prevalence of clinical depression or the expansion of diagnostic criteria to encompass ordinary emotional suffering. Proponents of the medicalization hypothesis argue that Western biomedical frameworks pathologize adaptive responses to stress, such as grief or mild dysphoria, leading to higher prescribing without corresponding increases in severe pathology.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2475322/) This view contrasts with interpretations favoring intrinsic cultural differences in psychopathology, where low consumption in regions like Asia reflects alternative expressions of distressâ€”often somatic rather than psychologicalâ€”rather than deficient detection.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10092833/)\n\nIn Asian contexts, antidepressant use remains notably subdued, with studies documenting lower utilization among Asian populations even when depression symptoms are comparable to Western norms, attributed to cultural preferences for non-pharmacological coping, including family support and traditional remedies, alongside persistent stigma against mental health labeling.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6534115/) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC2805045/) These patterns do not appear to signal undertreatment, as cross-cultural comparisons reveal no proportional deficits in overall functioning or resilience metrics; Eastern societies often exhibit lower reported anxiety and depression alongside adaptive social structures that mitigate distress without routine medication.[](https://www.psychologytoday.com/us/blog/talking-apes/201711/east-west-cultural-differences-in-depression)\n\nCritics of prevailing epidemic models question causal attributions linking low Eastern consumption to hidden morbidity, emphasizing instead that diagnostic fashions in the West amplify perceived disorder rates absent rigorous evidence of escalating true incidence.[](https://www.nytimes.com/2010/01/10/magazine/10psyche-t.html) Empirical data underscore cultural variance in symptom idiomâ€”physical complaints dominating in Asia versus cognitive-affective foci in the Westâ€”suggesting that global disparities owe more to interpretive lenses than universal pathology gradients.[](https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.00574/full) Such perspectives urge caution against assuming Western norms as benchmarks, highlighting how resilience-oriented Eastern approaches may avert unnecessary intervention without compromising well-being.[](https://deconstructingstigma.org/guides/eastern-western-mh)"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761886928760,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"Antidepressant drug consumption per 1000 people - Our World in Data\",\"description\":\"Daily intake of antidepressants per 1000 people, calculated as the 'defined daily dose'. This enables us to compare overall levels of drug consumption,Â ...\",\"url\":\"https://ourworldindata.org/grapher/antidepressants-per-capita\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.statista.com/chart/28358/antidepressant-consumption-daily-doses-per-100-population/\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"Antidepressant Use by Country 2025 - World Population Review\",\"description\":\"The most concentration of antidepressants by country between 2016 and 2020 comes from Iceland, Portugal, Canada, Australia and Sweden.\",\"url\":\"https://worldpopulationreview.com/country-rankings/antidepressant-use-by-country\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"Pharmaceutical consumption: Health at a Glance 2023 | OECD\",\"description\":\"Consumption of antidepressant medicines increased by nearly 50% in OECD countries between 2011 and 2021, more than tripling in Chile and doubling in Korea,Â ...\",\"url\":\"https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239/full-report/pharmaceutical-consumption_4b6cb013.html\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"a 10-year Comparative Analysis (2010â€“2020) - PMC - NIH\",\"description\":\"Findings reveal a significant increase in antidepressant consumption across most countries. The mean DDD value rose from 52.42 in 2010 to 69.5 in 2020. ThreeÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12213856/\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"Europe's mental health crisis: Which country uses the most ...\",\"description\":\"Dec 11, 2022 Â· The average antidepressant consumption across 18 European countries was 30.5 DDD per 1,000 people per day in 2000 rising to 75.3 DDD in 2020Â ...\",\"url\":\"https://www.euronews.com/health/2023/09/09/europes-mental-health-crisis-in-data-which-country-uses-the-most-antidepressants\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"Five-Year Trends in SSRI Consumption: A Precision Medicine ...\",\"description\":\"Notably, Iceland had the highest SSRI consumption, while Latvia had the lowest among the selected countries. Additionally, a positive correlation was foundÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12111178/\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"Defined Daily Dose (DDD) - World Health Organization (WHO)\",\"description\":\"Defined Daily Dose (DDD): The assumed average maintenance dose per day for a drug used for its main indication in adults.Missing:  SSRIs SNRIs\",\"url\":\"https://www.who.int/tools/atc-ddd-toolkit/about-ddd\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"Global trends in antidepressant, atypical antipsychotic, and ... - NIH\",\"description\":\"Apr 26, 2023 Â· A cross-sectional time-series analysis by country from July 2014 to December 2019 utilizing IQVIA's Multinational Integrated Data AnalysisÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10132527/\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"Antidepressant Use in Low- Middle- and High-Income Countries - NIH\",\"description\":\"In low- and middle-income countries (LMICs), depression (38.4%) and sleep problems (31.9%) were the most common reasons for use. Prevalence of use was 2â€“4 timesÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10071359/\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.statista.com/topics/12402/depression-in-europe/\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.statista.com/statistics/1020727/antidepressants-pharmaceutical-consumption-in-portugal/\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"(PDF) International Trends in Antidepressant Consumption: a 10 ...\",\"description\":\"Mar 3, 2025 Â· The average consumption of antidepressants in 18 European countries was 30.5 of the defined daily dose (DDD) per 1000 people per day in 2000Â ...\u003c|control11|\u003e\u003c|separator|\u003e\",\"url\":\"https://www.researchgate.net/publication/389518947_International_Trends_in_Antidepressant_Consumption_a_10-year_Comparative_Analysis_2010-2020\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"[PDF] Country Health Profiles 2023 - OECD\",\"description\":\"Dec 15, 2023 Â· Antidepressant consumption increased significantly during the pandemic. One in six people in the EU have a mental health condition. SourceÂ ...\",\"url\":\"https://www.oecd.org/health/OECD-OBS-Launch-Country-Health-Profiles-2023.pdf\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"Antidepressant use is rising sharply around the world\",\"description\":\"Oct 6, 2016 Â· In South Korea, where antidepressant use is the lowest among the countries analyzed, the suicide rate is the highest in the developed world.Missing:  DDD Mexico Turkey\",\"url\":\"https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-11\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"The Growing Global Reliance on Antidepressants - Voronoi\",\"description\":\"Apr 30, 2024 Â· According to the latest OECD data, Iceland continues to have one of the highest levels of antidepressant use in the world - with an average consumption of 157Â ...\u003c|separator|\u003e\",\"url\":\"https://www.voronoiapp.com/healthcare/The-Growing-Global-Reliance-on-Antidepressants-1183\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"Psychotropic medicine consumption in 65 countries and regions ...\",\"description\":\"The total consumption of psychotropic medicines increased from 28Â·54 DDD per 1000 inhabitants per day in 2008 to 34Â·77 DDD per 1000 inhabitants per day in 2019.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9766760/\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"Antidepressant use on the rise in rich countries, OECD finds\",\"description\":\"Nov 20, 2013 Â· The use of antidepressants has surged across the rich world over the past decade, according to the Organisation for Economic Co-operation and Development.\",\"url\":\"https://www.theguardian.com/society/2013/nov/20/antidepressant-use-rise-world-oecd\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"Antidepressant use has doubled in rich nations in past 10 years\",\"description\":\"Dec 5, 2013 Â· Antidepressant use almost doubled in the second ranked country, Australia, its defined daily dose rising from 45 in 2000 to 89 in 2011.\",\"url\":\"https://www.bmj.com/content/347/bmj.f7261\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"Antidepressants: global trends | Health - The Guardian\",\"description\":\"Nov 20, 2013 Â· In every single country we looked at, consumption of anti-depressants has risen since 2000. But where has it risen the fastest?\",\"url\":\"https://www.theguardian.com/news/2013/nov/20/mental-health-antidepressants-global-trends\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"International Trends in Antidepressant Consumption: a 10-year ...\",\"description\":\"Mar 3, 2025 Â· Findings reveal a significant increase in antidepressant consumption across most countries. The mean DDD value rose from 52.42 in 2010 to 69.5Â ...\u003c|separator|\u003e\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/40029558/\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"International Trends in Antidepressant Consumption: a 10-year ...\",\"description\":\"Mar 3, 2025 Â· Countries with high antidepressant use and steep increases included Canada, Iceland, Portugal, and the United Kingdom. In particular, Canada andÂ ...\",\"url\":\"https://link.springer.com/article/10.1007/s11126-025-10122-0\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"cross-country comparison of trends in antidepressant dispensing ...\",\"description\":\"In 2013, antidepressant dispensing rates in Australia were nearly twice as high as those in the Netherlands (82.5 versus 44.3 DDD/1000/day) and increased to beÂ ...\",\"url\":\"https://www.publish.csiro.au/py/fulltext/PY23168\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"Use of Antidepressant and Anxiolytic Drugs in Scandinavian ...\",\"description\":\"Jan 5, 2024 Â· Sweden had the highest TI of antidepressants in both 2006 and 2021 (from 69.7 and 108.9 DDD per 1000 inhabitants per day, respectively), whileÂ ...\u003c|separator|\u003e\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1155/2024/5448587\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"[PDF] IQVIA Snapshot\",\"description\":\"The prevalence rate of people receiving antidepressants from community pharmacies in Canada increased from 14.8% to 16.6% between 2019 and 2021, and stabilizedÂ ...\",\"url\":\"https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/iqvia_2023_snapshot_antidepressants_2019-2022.pdf\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"[PDF] IQVIA Snapshot\",\"description\":\"In 2023, the prevalence rate of antidepressant use among women was approximately twice that of men in all provinces, peaking at 29.3% in the Atlantic provinces.\",\"url\":\"https://www.iqvia.com/-/media/iqvia/pdfs/canada/fact-sheets/snapshot-antidepressants-2024-en.pdf\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"\",\"description\":\"\",\"url\":\"https://www.statista.com/statistics/782335/antidepressants-pharmaceutical-consumption-spain/\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"\",\"description\":\"\",\"url\":\"https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70172\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"Utilization of antidepressants, anxiolytics, and hypnotics during the ...\",\"description\":\"Nov 25, 2022 Â· Antidepressant prescription fills increased between 13.5 % and 31.3 % at the end of 2020 in all age groups in Denmark and 17.4 % in youths inÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9691511/\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"Impact of the COVID-19 pandemic on antidepressant use in eleven ...\",\"description\":\"Jul 22, 2025 Â· This study aimed to explore the effects of the pandemic on dispensed volumes of antidepressants in outpatient settings in different regions of Europe\",\"url\":\"https://link.springer.com/article/10.1007/s00127-025-02962-9\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"Variation in general practitioners' follow-up of depressed patients ...\",\"description\":\"Nov 20, 2024 Â· Setting. Norway offers universal health care, ensuring all residents have equal access to medical care [13]. GP care is covered by the NationalÂ ...\",\"url\":\"https://academic.oup.com/fampra/article/42/2/cmae063/7905645\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"Multinational comparison of new antidepressant use in older adults\",\"description\":\"May 14, 2019 Â· Choice of antidepressant should be based on patient factors (clinical features, patient preference, etc) and medication factors (drugâ€“drugÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6530307/\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"Indications related to antidepressant prescribing in the Nivel-PCD ...\",\"description\":\"Apr 15, 2022 Â· This cross national drug utilization study helps understand the patterns of use of antidepressant drugs in two European countries and raisesÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0165032722001392\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"A repetitive cross-sectional study in 19 European countries\",\"description\":\"Mar 28, 2022 Â· Men used antidepressants less than women in 8/19 countries, across phases. In 13/19 countries, people with physical disability were more likelyÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8969158/\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"Changes in prescription of antidepressants and disability pension ...\",\"description\":\"Sep 17, 2019 Â· The aim was to investigate differences in the prescription of antidepressants during the transition to disability pension (DP) comparing DP due to back painÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6756318/\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"Macroeconomic determinants of antidepressant use - ScienceDirect\",\"description\":\"This study covers 19 OECD countries for the period 1997â€“2017.4 The dependent variable is the antidepressant consumption per person per year, and obtained fromÂ ...Missing:  differences | Show results with:differences\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0161893820300880\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"The Influence of Culture and Society on Mental Health - NCBI - NIH\",\"description\":\"In some Asian cultures, stigma is so extreme that mental illness is thought to reflect poorly on family lineage and thereby diminishes marriage and economicÂ ...Introduction Â· Culture, Society, and Mental... Â· Racism, Discrimination, and...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK44249/\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"Antidepressant use in 27 European countries: Associations with ...\",\"description\":\"Jan 2, 2018 Â· The 12-month prevalence of antidepressant use of 7.2% in 2010 is double a previous estimate of 3.7% in 2000, Reference Alonso, Angermeyer, Â ...\",\"url\":\"https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/antidepressant-use-in-27-european-countries-associations-with-sociodemographic-cultural-and-economic-factors/5AE6AFD0AC1D681AAE402F1B8D912AF3\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"The OECD Warns on Antidepressant Overprescribing\",\"description\":\"Nov 22, 2013 Â· Antidepressant consumption is not matched by an increase in global diagnoses, raising fresh concerns about overuse.\",\"url\":\"https://www.psychologytoday.com/us/blog/side-effects/201311/the-oecd-warns-antidepressant-overprescribing\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"Is depression overdiagnosed? Yes - PMC - NIH\",\"description\":\"Meta-analyses show striking gradients favouring antidepressant drugs over placebo for melancholic depression. Yet trials in major depression show minimalÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC1949440/\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"A three-country comparison of psychotropic medication prevalence ...\",\"description\":\"Sep 25, 2008 Â· The annual prevalence of any psychotropic medication in youth was significantly greater in the US (6.7%) than in the Netherlands (2.9%) and in Germany (2.0%).\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/18817536/\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"Multinational comparison of new antidepressant use in older adults\",\"description\":\"Antidepressant use in older adults varied 24-fold by country, with the UK, which has the most conservative treatment guidelines, being among the lowest.\",\"url\":\"https://bmjopen.bmj.com/content/9/5/e027663\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"Association between Antidepressant Prescribing and Suicide Rates ...\",\"description\":\"This study demonstrates a statistically significant, albeit weak, association between antidepressant prescribing and suicide rates within an OECD data set. MostÂ ...\",\"url\":\"https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0033-1357183?device=desktop\u0026innerWidth=412\u0026offsetWidth=396\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"Did the introduction and increased prescribing of antidepressants ...\",\"description\":\"Nov 25, 2020 Â· This study presented no ecological association between new introduction of antidepressants and subsequent decrease of suicide rates.\",\"url\":\"https://academic.oup.com/eurpub/article/31/2/291/6000721\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"Suicide Rates and Prescription of Antidepressants - Hogrefe eContent\",\"description\":\"Feb 14, 2024 Â· Results: Overall, both the antidepressant prescription prevalence and the suicide rate were increasing from 1990 to 2020 in the United States.Abstract Â· Methods Â· ResultsMissing:  consumption | Show results with:consumption\",\"url\":\"https://econtent.hogrefe.com/doi/10.1027/0227-5910/a000941\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"Suicide and use of antidepressants, by country, more than 19 years ...\",\"description\":\"Additional data demonstrating that \\\"suicide rates have tended to decrease more in European countries where there has been a greater increase in the use ofÂ ...\",\"url\":\"https://www.researchgate.net/figure/Suicide-and-use-of-antidepressants-by-country-more-than-19-years-of-simultaneous-data_fig1_239730883\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"The Top Countries for Antidepressant Use - Business Insider\",\"description\":\"Feb 4, 2016 Â· In South Korea, where antidepressant use is the lowest among the countries analyzed, the suicide rate is the highest in the developed world.\",\"url\":\"https://www.businessinsider.com/countries-largest-antidepressant-drug-users-2016-2\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"[PDF] Anti-depressants and Suicide\",\"description\":\"The contribution of the present paper is to provide new empirical estimates for the effects of SSRIs on suicide mortality by combining the statistical powerÂ ...\",\"url\":\"https://www.nber.org/system/files/working_papers/w12906/w12906.pdf\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"Association between antidepressant prescribing and suicide rates in ...\",\"description\":\"Results: Suicide rate has significant positive correlations with antidepressant rates (p=0.031) and unemployment (p=0.028).Missing:  comparison | Show results with:comparison\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/24105079/\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"[PDF] Mental health in the EU - European Parliament\",\"description\":\"Before the COVID-19 pandemic, in 2019, mental health problems affected around 84 million people in the EU (1 in 6 people), and these figures have only worsenedÂ ...\",\"url\":\"https://www.europarl.europa.eu/RegData/etudes/BRIE/2023/751416/EPRS_BRI%282023%29751416_EN.pdf\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"Express View: The happiest countries also rank among the highest ...\",\"description\":\"Mar 23, 2023 Â· The use of antidepressants increased nearly two and half times across Europe between 2000 and 2020, with Iceland in the top spot, followed immediately byÂ ...\",\"url\":\"https://indianexpress.com/article/opinion/editorials/express-view-the-happiest-countries-also-rank-among-the-highest-in-antidepressant-consumption-8513372/\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"Frequently Asked Questions | The World Happiness Report\",\"description\":\"It is true that antidepressant use has risen sharply in many European countries over the last 20 years, but this trend is not correlated with changes in lifeÂ ...\",\"url\":\"https://www.worldhappiness.report/faq/\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"U.S. drops in new global happiness ranking. One age group bucks ...\",\"description\":\"Mar 20, 2024 Â· Researchers point to striking generational divides. People aged 60 and older in the US reported high levels of well-being compared to younger people.\",\"url\":\"https://www.npr.org/sections/health-shots/2024/03/20/1239537074/u-s-drops-in-new-global-happiness-ranking-one-age-group-bucks-the-trend\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"The relationship between self-reported mental health and redeemed ...\",\"description\":\"Jun 7, 2016 Â· Other studies have demonstrated an association between socioeconomic status and mental health as well as the use of antidepressants [18â€“20].\",\"url\":\"https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0893-7\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"Initial severity and antidepressant benefits: a meta-analysis of data ...\",\"description\":\"Drug-placebo differences in antidepressant efficacy increase as a function of baseline severity, but are relatively small even for severely depressed patients.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/18303940/\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"Antidepressant Drug effects and Depression Severity: A Patient ...\",\"description\":\"The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms, and may be minimal or nonexistent,Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3712503/\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"Relapse rates with long-term antidepressant drug therapy - PubMed\",\"description\":\"Results: Across 11 maintenance treatment studies, the relapse rate was significantly different at 1 year for active drug (23%) versus placebo (51%). In additionÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/19526453/\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"Maintenance or Discontinuation of Antidepressants in Primary Care\",\"description\":\"Sep 29, 2021 Â· By 52 weeks, relapse occurred in 92 of 238 patients (39%) in the maintenance group and in 135 of 240 (56%) in the discontinuation group (hazardÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2106356\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"The impact of antidepressants and human development measures ...\",\"description\":\"Oct 10, 2023 Â· This study is a cross-national comparison of the correlates of antidepressant use, using data from the Organisation for Economic Co-operationÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10594156/\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"Medicalisation of misery to blame for soaring use of antidepressants ...\",\"description\":\"Nov 21, 2013 Â· Doctors across Europe are warning that the soaring use of antidepressants is down to growing pressure to \\\"medicalise\\\" unhappiness.\",\"url\":\"https://www.theguardian.com/society/2013/nov/21/prescribing-culture-blame-rise-antidepressants\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"A three-country comparison of psychotropic medication prevalence ...\",\"description\":\"Countries such as Germany, France and Italy have major government restrictionsâ€“in part due to the high costs of newer psychotherapeutic drugs and concerns aboutÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2569908/\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"Multinational Study Shows Increase in Youth Antidepressant Use\",\"description\":\"Across the study years, antidepressant prevalence of use was greater in U.S. youth than European youth. For example, U.S. youth had 50 percent greater use thanÂ ...\",\"url\":\"https://news.pharmacy.umaryland.edu/multinational-study-shows-increase-in-youth-antidepressant-use/\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"A Canadian Primary Care Sentinel Surveillance Network Study ...\",\"description\":\"The prevalence of AD prescribing increased from 9.20% in 2006 to 12.80% in 2012 (P \u003c 0.001).\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/26720825/\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"Overprescribing antidepressants: where's the evidence? - The BMJ\",\"description\":\"Jun 30, 2014 Â· Based on the available research evidence base, do we over-prescribe antidepressants? The only conclusion I believe has to be, yes. Nothing will change.\",\"url\":\"https://www.bmj.com/content/348/bmj.g4218/rapid-responses\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"Consumption and ocurrence of antidepressants (SSRIs) in pre- and ...\",\"description\":\"Jul 10, 2022 Â· Antidepressants consumption worldwide continues to increase, and has doubled in OECD countries between 2000 and 2017 (Figure 1) (OECD iLibrary).\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0048969722017491\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and ...\",\"description\":\"Therefore, our analysis included the first 5 medications listed across all years examined. Medication entries are listed in the databases by drug entry codesÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC419384/\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"Antidepressant Market Size, Trends \u0026 Share Report, 2027\",\"description\":\"The global antidepressant market size was valued at $14.93 billion in 2020 and is projected to reach $18.29 billion in 2027, exhibiting a CAGR of 2.9%.Missing:  data | Show results with:data\",\"url\":\"https://www.fortunebusinessinsights.com/antidepressants-market-105017\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"Influence of Patients' Requests for Direct-to-Consumer Advertised ...\",\"description\":\"Apr 27, 2005 Â· Patients' requests have a profound effect on physician prescribing in major depression and adjustment disorder.\",\"url\":\"https://jamanetwork.com/journals/jama/fullarticle/200780\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"Directâ€toâ€consumer advertising and the advancement of the ...\",\"description\":\"Jan 20, 2022 Â· One study suggested that television DTCA exposure may lead to an up to 10% increase in antidepressant use while print DTCA exposure may lead toÂ ...\",\"url\":\"https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1599\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"[PDF] Effects of Direct-to-Consumer Advertising on Medication Choice - KFF\",\"description\":\"Prior research on antidepressants suggests that DTCA increases the number of people receiving drug treatment for depression, lending fur- ther support to theÂ ...\",\"url\":\"https://www.kff.org/wp-content/uploads/2013/01/effects-of-direct-to-consumer-advertising-on-medication-choice-the-case-of-antidepressants.pdf\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"Antidepressant Use Rises in 10-Year Period | Psychiatric News\",\"description\":\"Two national surveys showed that the prevalence of major depression in adults rose from 3.3 percent in 1991-1992 to 7.1 percent in 2001-2002. â€œIt is difficultÂ ...\",\"url\":\"https://psychiatryonline.org/doi/full/10.1176/pn.44.17.0008\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"Astounding increase in antidepressant use by Americans\",\"description\":\"Oct 20, 2011 Â· The rate of antidepressant use in this country among teens and adults (people ages 12 and older) increased by almost 400% between 1988â€“1994 and 2005â€“2008.\u003c|separator|\u003e\",\"url\":\"https://www.health.harvard.edu/blog/astounding-increase-in-antidepressant-use-by-americans-201110203624\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"Depressive disorder (depression) - World Health Organization (WHO)\",\"description\":\"Aug 29, 2025 Â· Globally, an estimated 5.7% of adults suffer from depression. More women are affected by depression than men. Depression can lead to suicide.\",\"url\":\"https://www.who.int/news-room/fact-sheets/detail/depression\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"The drugs don't work for everyone. Doubts about the efficacy of ... - NIH\",\"description\":\"The drugs don't work for everyone. Doubts about the efficacy of antidepressants renew debates over the medicalization of common distress. Giovanni FrazzettoÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2475322/\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"Crossâ€cultural differences in depression between White British and ...\",\"description\":\"Oct 27, 2022 Â· In Western cultures, there is a greater distinction between mind and body, whereas such differentiation between physical and psychologicalÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10092833/\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"Depression and Antidepressant Use among Asian and Hispanic ...\",\"description\":\"Despite Asian Americans suffering similar level of depression as whites, they are the least likely to use antidepressants, as compared to whites and Hispanics.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6534115/\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"Antidepressant Use among Asians in the United States - PMC - NIH\",\"description\":\"Filipinos generally had the lowest rates of antidepressant use compared to other Asian ... cultural factors are associated with antidepressant use among AsianÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2805045/\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"East-West Cultural Differences in Depression | Psychology Today\",\"description\":\"Nov 20, 2017 Â· Western nations report high levels of subjective well-being but also high rates of anxiety and depression. In contrast, Eastern societies appearÂ ...\",\"url\":\"https://www.psychologytoday.com/us/blog/talking-apes/201711/east-west-cultural-differences-in-depression\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"The Americanization of Mental Illness - The New York Times\",\"description\":\"Jan 8, 2010 Â· Cultures became more â€œliterateâ€ as they adopted Western biomedical conceptions of diseases like depression and schizophrenia.\",\"url\":\"https://www.nytimes.com/2010/01/10/magazine/10psyche-t.html\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"An East Meets West Approach to the Understanding of Emotion ...\",\"description\":\"Mar 27, 2019 Â· This review firstly summarizes the pathogenesis and etiology of depression in terms of both Eastern and Western medical systems.\",\"url\":\"https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2019.00574/full\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"Blending Eastern Practices With Modern Mental Health Care\",\"description\":\"Apr 5, 2025 Â· Western culture often views psychological symptoms as problems to be solved. Eastern practices tend to focus on taking a deeper look into aÂ ...\",\"url\":\"https://deconstructingstigma.org/guides/eastern-western-mh\",\"favicon\":\"\"}],\"images\":[{\"id\":\"d9c80ee9221c\",\"caption\":\"Iceland flag\",\"url\":\"./_assets_/Flag_of_Iceland.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"d9c80ee9221c\",\"caption\":\"Flag of Iceland\",\"url\":\"./_assets_/Flag_of_Iceland.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"d9c80ee9221c\",\"caption\":\"Flag of Iceland\",\"url\":\"./_assets_/Flag_of_Iceland.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"0222641f519f\",\"caption\":\"Flag of Turkey\",\"url\":\"./_assets_/Flag_of_Turkey.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"d9c80ee9221c\",\"caption\":\"Flag of Iceland\",\"url\":\"./_assets_/Flag_of_Iceland.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"d9c80ee9221c\",\"caption\":\"Flag of Iceland\",\"url\":\"./_assets_/Flag_of_Iceland.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0}],\"fixedIssues\":[],\"slug\":\"List_of_countries_by_antidepressant_consumption\",\"title\":\"List of countries by antidepressant consumption\",\"content\":\"$1f\",\"description\":\"List of countries by antidepressant consumption\\n\\nIceland flag\\nA list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications,...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761582322\",\"contentLength\":\"48873\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"49171\",\"recentViews\":\"49171\",\"dailyAvgViews\":1639.0333251953125,\"qualityScore\":1,\"lastViewed\":\"1761886928\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761886928757,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"List_of_countries_by_antidepressant_consumption\"],\"queryHash\":\"[\\\"page\\\",\\\"List_of_countries_by_antidepressant_consumption\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"List of countries by antidepressant consumption\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"A list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization's defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability. This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/List_of_countries_by_antidepressant_consumption\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"List of countries by antidepressant consumption\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"A list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization's defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability. This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/List_of_countries_by_antidepressant_consumption\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"List of countries by antidepressant consumption\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:42.322Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"List of countries by antidepressant consumption\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"A list of countries by antidepressant consumption ranks nations according to their per capita utilization of antidepressant medications, standardized via the World Health Organization's defined daily dose (DDD) metric, which quantifies consumption as doses per 1,000 inhabitants per day to enable cross-country comparability. This measure, derived from pharmaceutical sales and prescription data compiled by bodies like the OECD, highlights pronounced variations, with Iceland recording the highest...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ZDljY2I3MWEtYjk1ZS00NzhmLWJiOTgtMmUwYWQwYzA4MGU2">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"List_of_countries_by_antidepressant_consumption\"}]}]\n"])</script></body></html>